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1. INTRODUCTION 
Endurance and ultra-endurance sports are becoming more and more popular, 
which are reflected by the increasing number of participants in different 
sporting events every year. People run marathons, ultramarathons, do triathlons 
and 100 km paddling marathons. At the same time different level athletes are 
looking for ways to optimize their performance by training and nutrition 
(Jeukendrup, 2011). In addition to athletes, military personnel are also trying to 
find ways to train or operate better on missions. However, there is discrepancy 
between the term „endurance ability“ in the sport and military contexts. In 
sports it is important to cover a certain distance with maximum speed or to 
perform as much work as possible in a certain time. In military context, it is 
more important to work with constant intensity for a very long time, often even 
until exhaustion and simultaneously dealing with sleep depriviation. These 
aspects of endurance ability could be affected by various dietary supplements. 
Caffeine is probably the most popular legal work-enhancing supplement on 
the market, but until 2004 it was prohibited by the rules of WADA (Burke et al., 
2006). Caffeine in its different forms is nowadays again widely used by 
endurance athletes and military personnel, because of its ability to enhance 
performance (Goldstein et al., 2010) and decrease somnolence (Adan et al., 
2008). Different aspects of caffeine intake have been extensively studied, 
however, mainly in temperate environmental conditions. There is still lack of 
data on the ergogenic effect of caffeine in high-temperature environment. 
Sodium citrate as a dietary supplement is not equally well known with 
caffeine, but it has some specific properties that could make it useful in sports. 
For example, sodium citrate increases plasma volume (Timpmann et al., 2012) 
and extracellular buffering capacity (Requena et al., 2005). The latter feature is 
more important in high-intensity activities, where large acid-balance disturbances 
occur. However, plasma volume is an important parameter reflecting the water 
status of the body. Dehydration is known to impair endurance performance 
(Cheuvront et al., 2010; Cheuvront and Kenefick, 2014) and should therefore be 
avoided, although during long-duration competitions or tours it is often 
impossible. Because of this, more attention should be paid to effective rehydration 
supporting recovery of plasma volume between training sessions or competition 
stages. Numerous studies about ingestion of sodium citrate have shown ergogenic 
effects mostly on short-term high-intensity exercises in temperate environment 
(Burke et al., 2006; Carr et al., 2011). Similarly to caffeine, there is lack of data 
on the ergogenic effect of sodium citrate in high-temperature environment.  
In conlusion, there is abundant information about dietary supplements, 
especially about caffeine, but obvious deficit of studies conducted in high-
temperature environment. Knowing that remarkable decrements in performance 
may occur in warm compared with temperate environment (Tatterson et al., 
2000), some dietary supplements could also affect the organism differently than 
they do in temperate conditions. Therefore, the aim of the current thesis was to 
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determine the effects of ingesting two dietary supplements, caffeine and sodium 
citrate, on endurance ability in recreationally active participants performing in 
the heat. This study will hopefully provide useful advice to athletes, coaches 
and military personnel who train/compete or operate in warm climates.  
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2. LITERATURE REVIEW 
2.1. Physiological and nutritional determinants of 
endurance ability 
Major physiological determinants of endurance ability are maximal oxygen 
uptake (VO2max), lactate threshold and exercise economy (Joyner and Coyle, 
2008; Midgley et al., 2007; Pate and Branch, 1992). All these factors can be 
significantly improved by systematic endurance training, but marked inter-
individual variability occurs in the magnitude of improvements. For example, 
Bouchard et al. (2011) engaged 473 sedentary adults into standardized 22-week 
continuous endurance training program and reported a mean increase in 
VO2max of 0.4 L·min–1, whereas in 7% of participants the gain was 0.1 L·min–1 
or less and 8% of participants showed improvement of 0.7 L·min–1 or more. The 
results of recent meta-analysis reveal that similar mean increase in VO2max 
(0.5 L·min–1) could be achieved much faster (within 6–13 weeks) if interval 
training or combined interval and continuous training programs are employed 
(Bacon et al., 2013). 
In previously sedentary participants, relative increases in VO2max in the 
range of 15–20% occur over 5.5 months of continuous endurance training 
(Skinner et al., 2001). An individual’s highest attainable VO2max that may 
exceed his or her baseline level up to 50% is usually reached within 18–24 
months of systematic endurance training (Hoffman, 2002; Wilmore and Costill, 
2004). After occurrence of plateau in VO2max, continuing training still 
increases lactate threshold and exercise economy. Based on these training 
adaptations, endurance ability can be markedly improved over many years 
without further increases in VO2max. For example, between 1992 and 2003 
Paula Radcliffe’s VO2max remained stable at approximately 70 ml·min–1·kg–1, 
but her lactate threshold and running economy increased by 15% and 24%, 
respectively (Jones, 2006). 
In addition to VO2max, lactate threshold and exercise economy that can be 
improved through systematic training, there are other factors, including nutrition 
and hydration, that influence endurance ability in a more acute manner. Modern 
scientific understanding about nutritional factors influencing endurance ability 
is largely based on studies of Scandinavian exercise physiologists who introduced 
needle biopsy method for investigation of the impact of exercise and nutrition 
on human skeletal muscle structure and function in the 1960s. One of their 
classical studies convincingly demonstrated strong positive association between 
food carbohydrate content, muscle glycogen concentration and endurance capa-
city (Bergström et al., 1967). They also were the first to show that if glucose is 
infused continuously during endurance exercise, muscle glycogen use is 
significantly lower if no glucose is administered (Bergström and Hultman, 
1967). American researchers demonstrated that oral ingestion of carbohydrates 
during prolonged exercise could improve endurance capacity (Coyle et al., 
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1983; Ivy et al., 1983) and endurance performance (Murray et al., 1989; Neufer 
et al., 1987). Many studies conducted in the 1990s revealed that peak rates of 
exogenous carbohydrate oxidation during prolonged exercise are approximately 
1g·min–1 (for review, see Jeukendrup and Jentjens, 2000). However, Jentjens et 
al. (2004) demonstrated that combined ingestion of carbohydrates possessing 
different intestinal transport mechanisms (glucose and fructose) may increase 
exogenous carbohydrate oxidation rates to the level of approximately 1.3 g·min–1. 
Later Currell and Jeukendrup (2008) reported a marked performance benefit 
with ingestion of glucose and fructose compared with glucose alone in cyclists 
during exercise of approximately 3-h duration.   
Carter et al. (2004) were the first to demonstrate that rinsing the mouth with a 
carbohydrate solution significantly improved performance during approximately 
1 h cycling time-trial (TT) even when their endurance-trained participants did 
not swallow the carbohydrate. Pottier et al. (2010) reported that rinsing the 
mouth with, but not ingesting the carbohydrate-electrolyte solution (6% carbo-
hydrates), resulted in improved performance during similar cycling TT in trained 
triathletes. Generally, carbohydrate mouth rinse is considered to improve 
endurance performance during exercise of moderate (65–75% VO2 max) to high 
(>75% VO2max) intensity and during relatively short durations (∼1 h) 
(Jeukendrup, 2014; Jeukendrup and Chambers, 2010; Stellingwerff and Cox, 
2014), and the positive effect seems to be accentuated when muscle and liver 
glycogen stores are reduced (Ataide-Silva et al., 2014; Rollo and Williams, 
2011). However, recent findings suggest that in high-temperature environments 
the ergogenic effect of carbohydrate mouth rinse may disappear (Chryssantho-
poulos et al., 2018; Watson et al., 2014).  
Whole body sweating rates during exercise vary widely and may reach from 
the common range of 0.5–1.5 L·h–1 in temperate environments (Baker et al., 
2016) to values as high as 2.5–4 L·h–1 in the heat (Baker et al., 2016; Sawka and 
Montain, 2000; Taylor and Machado-Moreira, 2013). As athletes usually do not 
drink enough to compensate water loss, they dehydrate during prolonged 
exercise (Atkinson et al., 2003), while the magnitude of their acute dehydration 
is reflected in body mass (BM) loss (Baker et al., 2009). Literature suggests that 
dehydration in the magnitude of ≥ 2% of BM impairs endurance exercise 
performance (Cheuvront et al., 2010; Cheuvront and Kenefick, 2014). Recent 
meta-analysis revealed that the ergogenic effect of fluid ingestion during 
endurance cycling depends on the intensity and duration of exercise (Holland et 
al., 2017). Compared with no fluid intake, the average performance improve-
ments of 2.1% and 3.2% might occur when fluid is consumed in a volume 
sufficient to limit the loss of BM below 2% during moderate-intensity cycling 
exercise of > 1 h to ≤ 2 h and > 2 h duration, respectively. During high-intensity 
cycling task of ≤ 1 h duration, fluid consumption compared with no fluid intake, 
despite preventing ≥ 2% loss of BM, decreases performance by 2.5% on 
average (Holland et al., 2017). However, the meta-analysis of Holland et al. 
(2017) involved only one study where participants performed 1 h cycling TT in 
the heat. The authors of this study reported that compared with no fluid intake, 
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the ingestion of water in volume replacing 100% of sweat losses had no effect, 
positive or negative, on performance (Kay and Marino, 2003). In previously 
dehydrated participants, Arnaoutis et al. (2012) demonstrated that ingestion of a 
small amount of water (25 mL every 5 min), compared with mouth rinse or no 
fluid manipulation, significantly increased endurance capacity in cycling test at 
75% of maximum power output in the heat. 
Sports foods and supplements possessing proved property to acutely improve 
endurance ability are sports drinks, sports gels, sports bars, energy drinks, 
caffeine (CAF), dietary nitrate, and during ultra-endurance activities, electrolyte 
replacements (Maughan et al., 2018). Some, but not convincing, evidence 
suggest that acute ingestion of sodium bicarbonate (NaHCO3), or sodium citrate 
(CIT) may enhance endurance ability (Carr et al., 2011).  
 
 
2.2. Impact of high environmental temperature on 
endurance ability 
Remarkable decrements in physical performance may occur in a warm environ-
ment compared to temperate climatic conditions (Galloway and Maughan, 
1997; Tatterson et al., 2000). In laboratory experiments mostly two different 
methods are used for evaluating endurance ability: 1) participants work with 
constant intensity until exhaustion (endurance capacity); 2) participants cover a 
certain distance as fast as possible or perform as much work as possible in a 
certain time (endurance performance). Studies using the above methods have 
demonstrated that heat stress significantly degrades aerobic performance 
(Galloway and Maughan, 1997; Tatterson et al., 2000). Galloway and Maughan 
(1997) conducted one of the first studies to examine the effects of temperature 
on endurance capacity. They used an ambient temperature range of 4–31 °C and 
demonstrated approximately 42 min shorter time to exhaustion (70% of 
VO2max) in the warmest environment compared to the study optimum (11 °C). 
However, Ely et al. (2007) evaluated the impact of warm weather on endurance 
performance and found that marathon finishing times progressively worsened 
with increased wet-bulb globe temperature over a range of 5 °C to 25 °C. This 
finding seems true for both sexes, but data indicate that slower runners suffered 
a greater decrement in finishing time than faster runners. 
The mechanisms responsible for the reduced endurance ability in the heat are 
not entirely clear and vary between current situations. Nevertheless, endurance 
ability could be impaired in the heat because of changes in energy metabolism, 
cardiovascular function and fluid balance, central nervous system (CNS) 
function and motor drive (Hargreaves, 2008). Cardiovascular mechanisms were 
for a long time assumed to be the primary factor impairing submaximal 
performance in the heat, but later findings (Nielsen et al., 1993; Nybo, 2008; 
2012) confirmed the critical core body temperature (Tc) hypothesis according to 
which the primary mechanism impairing submaximal aerobic performance in 
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the heat is elevated core temperature that in turn causes hyperthermia. 
Hyperthermia occurring during exercise has been defined as an elevation of Tc 
above 38 °C (IUPS Thermal Commission, 1987). This hypothesis has been later 
marked as questionable and the new standpoint reflects that elevated skin 
temperature could be responsible for impaired endurance performance in the 
heat (Cheuvront et al., 2010; Sawka et al., 2012). 
The water status of the organism influences skin and core temperature during 
exercise in the heat and thereby performance. When the ambient temperature is 
higher than skin temperature, the only mechanism by which heat can be lost 
from the body is evaporation of water from the skin and respiratory tract 
(Maughan, 2006). High fluid loss during exercise, which is not replaced, causes 
dehydration. This in turn reduces stroke volume, cardiac output, blood pressure, 
muscle blood supply and tolerance of hyperthermia (Nybo, 2008). Fatigue 
associated with dehydration may induce performance impairment and is most 
evident during endurance exercise in warm humid conditions where sweat rates 
are high (Maughan and Shirreffs, 2008). Already ca 2% of fluid loss from initial 
euhydrated body mass impairs endurance performance (Coyle, 2004) and in 
warm climate even lower dehydration level may impair performance (Bardis, 
2013). 
The combination of hyperthermia and dehydration is considered to be the 
main cause of fatigue and impaired performance in high-temperature environ-
ment (Hargreaves, 2008). Therefore, the primary goal should be preventing it. 
Dehydration can be avoided with sufficient drinking regimen and according to 
Hargreaves, (2008) hyperthermia can be attenuated by using strategies like 
acclimatization, pre-cooling and fluid ingestion. In addition to these factors, 
there are some dietary supplements that might help to improve endurance 
ability. CAF is the worldʼs most widely consumed legal CNS stimulant and 
meta-analysis conducted by Doherty and Smith (2005) revealed that in temperate 
environmental conditions, CAF, compared with placebo (PLC), may increase 
exercise performance by approximately 11% and that an average 5.6% reduction 
in ratings of perceived exertion (RPE) obtained during exercise may account for 
approximately 29% of the ergogenic effect of this drug. A concious decision is 
necessary to start voluntary exercise and although it is not clear what forces the 
recruitment of motor units, the end of effort is again volitional and a concious 
decision precedes it (Kayser, 2003). Therefore, the perception of effort is an 
important factor that limits exercise. Reduction in RPE is considered one of the 
main CNS related actions of CAF leading to improved endurance in temperate 
environments (Tarnopolsky, 2008). 
In elite cyclists competing in temperate environmental conditions modest 
BM loss of 1.3% has been observed (Ross et al., 2014), but in warm weather 
professional cyclists typically lose 2.1–4.5 kg of BM after a stage (Atkinson et 
al., 2003). Considering an average BM of 69 kg for a cyclist (Mujika and 
Padilla, 2001), this means dehydration in the range of 3.0–6.5% that may lead to 
a decrease in plasma volume (PV) up to 16% (Baker et al., 2009; van Rosendal 
et al., 2012). Decreased PV in turn impairs performance and the expansion of 
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PV has been suggested to improve thermoregulation and exercise performance 
in the heat (Sims et al., 2007b). Compared with temperate environmental 
conditions, muscle (Febbraio, 2001) and blood (Febbraio et al., 1994; McAnulty 
et al., 2005) lactate accumulation is augmented during exercise in the heat, 
suggesting more severe acidosis (Robergs et al., 2004). CIT or NaHCO3 are 
used with intention of increasing extracellular fluid buffering capacity (Requena 
et al., 2005) that may improve performance in situations where marked 
disturbances in acid-base balance occur (Ibanez et al., 1995). Therefore, CIT 
supplementation may improve endurance ability in the heat by increasing both 
PV and extracellular buffering capacity. 
 
 
2.3. Impact of caffeine on endurance ability 
CAF (1,3,7-trimethylxanthine) is a widely used ergogenic supplement by 
athletes at different levels of fitness and different fields of sporting disciplines 
(Del Coso et al., 2011). CAF absorption from the gastrointestinal tract is very 
quick: elevated levels can appear in bloodstream within 15–45 min after 
ingestion and peak concentrations appear approximately 1 h post ingestion 
(Goldstein et al., 2010). Besides timing, CAF’s ergogenic effect could be 
affected by the method of administration (capsule vs liquid), dose (3–6 mg·kg–1 
is optimal), habituation and training status (Graham, 2001). 
It is also relevant to note that the physiological and psychological responses 
to CAF may differ between the sexes (Temple and Ziegler, 2011). CAF-induced 
increases in subjective activation and decreases in somnolence are greater in 
men than in women (Adan et al., 2008); adolescent males compared with 
females feel caffeinated soda to be more reinforcing (Temple et al., 2009) and 
are more likely to perceive getting a rush, having more energy, or having an 
improved athletic performance from CAF (Temple et al., 2010). Increased 
activeness and alertness may provide a psychophysiological advantage in 
exercise performance (Hull et al., 2003). In addition, CAF has anxiety-related 
properties (Botella and Parra, 2003), and anxiety sensitivity has been found to 
moderate a negative psychological response to CAF (Keogh and Chaloner, 
2002; Telch et al., 1996), especially in women (Keogh and Birkby, 1999). 
Goldstein and colleagues (2010) pointed out that research on the ergogenic 
effects of CAF in women is limited, exceptionally varied and, therefore, 
additional research is needed to determine if CAF is effective in enhancing 
performance in females.  
CAF enhances performance in a wide range of physical activities, with the 
ergogenic effect occurring more consistently in endurance tasks than in high-
intensity or strength and power exercises (Astorino and Roberson, 2010; 
Doherty and Smith, 2004; Goldstein et al., 2010). However, current knowledge 
of CAF’s impact on endurance is based mainly on the findings of studies 
conducted in temperate environments, whereas data on the ergogenic effect of 
CAF in the heat are scarce and inconsistent. 
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2.3.1. Mechanism of action 
The mechanisms that cause the ergogenic effects of CAF are not fully 
understood. Nevertheless, strong evidence from animal experiments (Davis et 
al., 2003) suggests that blockage of the adenosine receptors in the CNS may 
explain the fatigue-delaying and endurance-enhancing properties of CAF. 
According to Tarnopolsky, (2008) CAF is likely to improve endurance through 
CNS-related mechanisms in humans as well.  
Adenosine is a neurotransmitter the molecule of which is similar in structure 
to CAF and has been shown to cause tiredness, enhanced pain perception and 
reduced arousal (Davis and Green, 2009). Adenosine receptors are found 
throughout the body and because of their similar chemical structure, CAF can 
bind adenosine receptors and work against the actions of adenosine (Burke et 
al., 2013). Adenosine receptors are classified into four: A1, A2A, A2B and A3 
(George, 2003). The main targets for CAF are A1 and A2A receptors, which bind 
CAF already in small amounts. However, A2B receptors respond only to high 
doses of CAF and A3 receptors are not affected by CAF at all (Fredholm et al., 
1999). 
Adenosine inhibits the release of other neurotransmitters, whereas CAF 
causes elevated levels in them. CAF affects neurotransmitters like nore-
pinephrine, dopamine, serotonin, acetylcholine, glutamate and gamma-amino-
butyric acid (Fredholm et al., 1999). For example, the longer time the person is 
awake, the higher concentrations of adenosine in the brain are found, which in 
turn causes even greater fatigue (Fredholm et al., 1999). Inversely, CAF is 
known to have the opposite effect by stimulating alertness and reducing fatigue. 
CAFcan pass through the blood-brain barrier and therefore it is very difficult 
to distinguish whether the performance enhancing effect results from the CNS 
or muscle level. One possible option is that CAF can affect substrate utilization 
during exercise and decreases reliance on glycogen (Goldstein et al., 2010). 
CAF ingestion leads to an increased lipolysis in adipose tissue and therefore 
increased level of free fatty acids. In turn, free fatty acids are alternative energy 
sources to spare the limited stores of glycogen in the muscle (Graham, 2001; 
Tarnopolsky, 1994). If CAF could increase fat utilization during exercise, it 
would allow glycogen stores to be used at a slower rate and be available at the 
end of longer exercise tasks (Burke et al., 2013) and thereby endurance ability 
could be improved.  
 
 
2.3.2. Endurance performance 
World Anti-Doping Agency (WADA) removed CAF from the prohibited list in 
2004. Thereafter Del Coso et al. (2011) conducted a study to describe the use of 
CAF in sports. They found that 74% of elite athletes used CAF as an ergogenic 
aid during national and international competitions and endurance sports like 
triathlon, cycling and rowing showed the highest prevalence rate for CAF use.  
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According to Southward et al. (2018) acute CAF ingestion has a small but 
significant effect on endurance performance. In their meta-analysis, average TT 
time was 2.2% faster in CAF compared to PLC trials and mean power output 
followed the similar pattern. However, there are large inter-individual responses 
to CAF ingestion.  
CAF ingestion shortens the time to finish a certain running (O’Rourke et al., 
2008; Wiles et al., 1992) and cycling distances (Astorino et al., 2012; Skinner et 
al., 2013). Running times in 1500 m on a treadmill improved 4.2 s on average in 
CAF compared to PLC trial (Wiles et al., 1992). CAF ingestion also 
significantly improved 5-km running TT around a 400 m athletics track. In 
comparison to the PLC, the CAF trial resulted in 1.1% and 1.0% faster times for 
the well-trained and recreational runners, respectively (O’Rourke et al., 2008). 
Astorino et al. (2012) used 10-km cycling test on veloergometer to evaluate 
CAF impact on endurance performance on 2 consecutive test days. The results 
showed that with CAF ingestion the distance was covered 1.6% faster on the 
first day and 1.9% faster on the second day compared to PLC. Skinner et al. 
(2013) also found improved cycling performance when CAF was ingested 60 
min prior to testing. Their participants cycled 40-km TT 70.5 s faster (2%) in 
CAF compared to PLC trial. 
 
 
2.3.3. Endurance capacity 
In previous well controlled laboratory studies, cycling TT protocols have been 
used exclusively (Southward et al., 2018). It is important to note that central 
fatigue (failure to sustain CNS drive to working muscle) is considered a more 
critical performance limiting factor in endurance running than in cycling (Millet 
et al., 2009). However, the vast majority of CAF studies conducted in the heat 
used cycle ergometer protocols (Cheuvront et al., 2009; Ganio et al., 2011; 
Pitchford et al., 2014; Roelands et al., 2011). Furthermore, a meta-analysis 
conducted by Doherty and Smith, (2004) revealed that time to exhaustion 
protocols are much more likely to elicit a positive effect of CAF on endurance 
ability than are TT-s or distance trials. 
Data of CAF ingestion in the amount of 3–7 mg·kg–1 show ca 24% improved 
endurance capacity in time to exhaustion protocols in case of both treadmill and 
veloergometer trials (Goldstein et al., 2010). For example, CAF ingestion 
extended time to exhaustion 31% compared to PLC capsules and 22.8% 
compared to decaffeinated coffee in young fit adults who ran on a treadmill 
(Graham et al., 1998). However, Hogervorst et al. (2008) found 84% 
improvement in endurance capacity after CAF ingestion compared to PLC 
ingestion in cycling test until exhaustion.  
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2.3.4. Endurance ability in the heat 
Although the ergogenic effect of CAF in thermoneutral environmental 
conditions has generally shown performance benefits, its efficacy in warm 
conditions is not so well known and results are controversial. Many researchers 
like Cohen et al. (1996), Cheuvront et al. (2009), and Roelands et al. (2011) 
observed no benefits of acute CAF ingestion on TT performance in the heat, but 
Ganio et al. (2011) found CAF to be equally ergogenic in both cool and warm 
environments. However, Pitchford et al. (2014) reported a worthwhile 
improvement in performance in the heat after CAF compared with PLC 
ingestion, although the difference between the two treatments did not reach 
statistical significance. 
Cohen et al. (1996) conducted a field study with 7 endurance trained runners 
who performed 3 maximal-effort 21 km road races outdoors in warm (24‒
28 °C) and humid conditions. CAF ingestion 60 min before the start did not 
improve the running time. A possible explanation for this could be that the 
participants were ca 4% dehydrated by the end of the race. Dehydration, 
especially in excess of 2% of body mass and combined with a high skin 
temperature, markedly impairs endurance performance (Sawka et al., 2012). In 
Cohen et al. (1996) study the fatigue caused by dehydration assumably hindered 
the ergogenic effect of CAF. It is also important to note that the study 
conducted by Cohen and colleagues (1996) seems to be the only one where the 
potential ergogenic effect of CAF in warm environment has been examined in 
female participants. 
An increase in Tc is considered to be one of the major causes of fatigue in 
warm climate (Hargreaves, 2008). It has been found that hyperthermia increases 
CNS fatigue, which in turn reduces performance (Nybo, 2008). Cheuvront et al. 
(2009) and Roelands et al. (2011) administered a single 6–9 mg·kg–1 dose of 
CAF to their participants and reported that CAF increased Tc during exercise in 
the heat. Furthermore, Roelands et al. (2011) suggested that this thermogenic 
effect might negate any potential ergogenic benefit of CAF in the heat. 
Pitchford et al. (2014) speculated on the basis of their own findings and those of 
Ganio et al. (2011) that relatively small doses of CAF, or a distribution of 
bigger doses, may prevent the thermogenic effect of CAF and increase the 
likelihood of an ergogenic effect of this drug in warm conditions.  
The majority of studies have not found positive effect of CAF ingestion on 
endurance ability in the heat (Cheuvront et al., 2009; Cohen et al., 1996; 
Roelands et., 2011). The exception is Ganio et al. (2011) study, which 
compared the effect of CAF (6 mg·kg–1) on endurance performance in moderate 
(12 °C) and warm (33 °C) environment. In the latter study participants had to 
cycle 90 min with the intensity of 60–70% of their VO2max and after that 15 
min as fast as possible. High environmental temperature reduced endurance 
performance 19% regardless of the substance, while CAF improved endurance 
performance 5% compared to PLC in both environmental conditions. Therefore, 
it can be assumed that this time CAF shadowed hyperthermia. 
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2.4. Impact of sodium citrate on endurance ability 
Several nutritional strategies have been studied over the decades to delay the 
onset of muscle fatigue, which is one of the main limiting factors affecting sports 
performance (Robergs et al., 2004). The problem is complex and scientists do 
not agree about the exact causes of fatigue. Muscle fatigue may originate in 
changes in the muscle itself (peripheral fatigue) or proceed from the CNS 
(central fatigue) (Fitts, 2004). Despite the lack of consensus, the accumulation 
of hydrogen ions (H+) within the muscle cell has been emphasized as a major 
cause of fatigue during high-intensity, short duration exercise (Robergs et al., 
2004). Therefore, many nutritional strategies aiming to increase intra- and 
extracellular buffering capacity, such as beta-alanine, NaHCO3, CIT, have been 
investigated and applied to postpone muscle fatigue (Lancha Junior et al., 
2015). 
NaHCO3 or CIT loading is not prohibited by the rules of sport and therefore, 
athletes have practiced “soda loading” for more than 80 years, with NaHCO3 
being ingested in the form of household product “bicarb soda” (Burke et al., 
2006). Ingestion of alkalizing substances improves performance in high-
intensity short duration exercise, but results from longer duration exercises that 
last more than 10 min are considered inconclusive (Carr et al., 2011; Requena et 
al., 2005). However, only three studies have addressed the potential ergogenic 
effects of these substances on endurance cycling. Two of these studies reported 
enhanced endurance performance owing to NaHCO3 (McNaughton et al., 1999) 
or CIT (Potteiger et al., 1996) ingestion, whereas the third study (Schabort et 
al., 2000) found no impact of CIT on endurance performance. Studies where 
endurance ability was improved after CIT ingestion used 500 mg·kg–1 doses and 
the time interval from intake to the beginning of exercise was ca 120 min 
(Requena et al., 2005).  
 
 
2.4.1. Mechanism of action 
CIT does not exist in molecular form in body fluids and dissociates quickly into 
Na+ and citrate– ions immediately after ingestion. The citrate anion is expelled 
from the plasma and electrical equilibrium becomes unbalanced (Kowalchuk et 
al., 1989). In order to restore this equilibrium, H+ concentration in plasma 
decreases and HCO3– concentration increases, and thus the extracellular buffering 
capacity enhances (McNaughton and Cedaro, 1992). Ingestion of CIT increases 
HCO3– concentration in extracellular space, which in turn may facilitate a 
greater efflux of lactate and H+ out of the working muscle (Lancha Junior et al., 
2015). During high-intensity exercise accumulating H+ binds with bicarbonate 
and forms carbonic acid, which reduces acidification of intracellular space and 
thereby may enhance performance (Requena et al., 2005). 
The generation of lactic acid in the muscles during high-intensity exercise 
results in lowered pH of the muscle and blood due to the dissociation of lactic 
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acid into lactate and H+ (Abbiss and Laursen, 2005). Increased lactate con-
centration together with concomitant rise in H+ could induce fatigue by various 
mechanisms like inhibition of phosphofructokinase and thus the glycolytic rate, 
competitive inhibition of Ca2+ binding to troponin C reducing cross-bridge 
activation, and inhibition of sarcoplasmic reticulum ATPase (Fitts, 2004). 
However, it appears that the intracellular accumulation of lactate and H+ per se 
are not the major factors in muscle fatigue (Allen et al., 2008). Despite those 
findings, high-intensity exercise still could be enhanced by increased extra-
cellular (Carr et al., 2011) or intracellular (Quesnele et al., 2014) buffer capacity. 
The majority of previous studies have focused on ergogenic effects of 
alkalizers based mainly on their property to increase extracellular buffer 
capacity (Bishop et al., 2004; McNaughton et al., 1999; Potteiger et al., 1996), 
whereas their impact on exercise-induced stress has received less attention. 
Stress is a complex and multifactorial phenomenon that affects performance, but 
physiological responses to stress generally comprise changes in neuroendocrine, 
hormonal and immune functions (Kozlov and Kozlova, 2014; Glaser and 
Kiecolt-Glaser, 2005). By increasing the body’s buffer capacity (Potteiger et al., 
1996; Timpmann et al., 2012) and PV (Timpmann et al., 2012; Ööpik et al., 
2010), CIT may facilitate maintenance of homeostasis, i.e. reduce physiological 
stress during heavy exercise. Available data suggest that acute orally induced 
metabolic alkalosis alleviates exercise stress, as reflected in attenuated stress 
hormone responses to intense exercise (Bouissou et al., 1988; Gordon et al., 
1994; Rojas Vega et al., 2006; Wahl et al., 2010; Ööpik et al., 2010). However, 
the findings of Marx et al. (2002) and Bracken et al. (2005) are not consistent 
with these data, as they did not observe any impact of NaHCO3 or CIT, 
respectively, on blood catecholamine responses to high-intensity exercise. 
 
 
2.4.2. Endurance performance 
The ergogenic effects of NaHCO3 and CIT on short-term high-intensity exercise 
have been well documented with numerous investigations (Burke et al., 2006; 
Carr et al., 2011; Requena et al., 2005). Results obtained after long-term exercise 
are much more limited, because investigations are scarce and the existing data 
are controversial (Requena et al., 2005).  
Potteiger et al. (1996) investigated trained male cyclists who ingested 
500 mg·kg–1 of CIT or PLC prior to 30-km TT. Significantly higher pH values 
were observed throughout the TT with CIT compared to PLC. The authors 
concluded that CIT ingestion created a favourable metabolic condition that 
probably contributed to 4% improvement during the time of covering 30-km TT. 
Improved performance was also found in McNaughton et al. (1999) study, 
where well-trained male cyclists ingested 300 mg·kg–1 of NaHCO3 before 
60 min maximal cycle ergometer test. The NaHCO3 increased plasma bicarbo-
nate concentration prior to the start of the test and the participants completed 
significantly more work in NaHCO3 trial than in control or PLC trial. The 
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authors suggested that NaHCO3 ingestion may be used to offset the fatigue 
process during high-intensity cycling. 
Contrary to the two previous studies (McNaughton et al., 1999; Potteiger et 
al., 1996), Schabort et al. (2000) did not find any significant enhancement in  
40-km TT time or in the average power output after administering 200–
600 mg·kg–1 of CIT, although there emerged dose-dependent changes in pH, 
base excess and bicarbonate concentrations. The authors suggested that the 
failure of CIT to enhance performance was due to gastrointestinal discomfort 
and stomach cramps, which were experienced by 5 out of 8 trained cyclists. 
Ööpik et al. (2003) studied well trained male college runners who performed 
a 5 km treadmill run with and without preceding CIT ingestion. The CIT dose 
was 500 mg·kg–1 dissolved in 1 litre of water two hours before the run. The 
authors reported significantly improved endurance performance in CIT 
compared to PLC trial. However, the subsequent study carried out on outdoor 
stadium where the participants (trained male runners) competed in pairs against 
each other, did not confirm the ergogenic effect of CIT (500 mg·kg–1 dissolved 
in water) on 5 km running performance (Ööpik et al., 2004). It remains unclear 
why this dietary manipulation enhances endurance performance on treadmill but 
not in field conditions. Ööpik et al. (2004) speculated that the ingestion time of 
CIT might have been too early before the run. The solution was consumed 180 
min before exercise within 60 min period contrary to Ööpik et al. (2003) study, 
where CIT was consumed 120 min before the start within 10 min. Ööpik et al. 
(2004) also assumed that the positive effect of CIT might have been negated by 
the uncontrollable variables presented in the real competitive environment. 
 
 
2.4.3. Endurance capacity 
Data regarding the potential effects of CIT on endurance capacity are scarce. 
Ööpik et al. (2010) administered 500 mg·kg–1 of CIT to well trained runners 
who performed an incremental running test to volitional exhaustion on a 
treadmill. Solution containing CIT increased PV (ca 6.4%) more than PLC 
drink (ca 4.1%). According to Mora-Rodriquez and Hamouti (2013) expansion 
of PV in the range of 7–8% may improve endurance capacity. However, Ööpik 
et al. (2010) did not find differences between CIT and PLC treatments in perfor-
mance time to exhaustion. Probably the increase in PV in CIT trial was not that 
much higher (ca 2.3%) compared to PLC trial. Another explanation why 
endurance capacity was not improved, could be that 12 participants out of 13 
complained gastrointestinal distress symptoms after CIT ingestion.  
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2.4.4. Endurance ability in the heat 
Compared with temperate environment, exercise in the heat places a higher 
demand on the body’s thermoregulatory system and induces sweat losses that 
may reach 3–4 L·h−1 in trained athletes (Taylor and Machado-Moreira, 2013). 
Although lower sweating rates of 1.0–2.5 L·h−1 are more common (Sawka and 
Montain, 2000), athletes still do not drink enough to avoid dehydration, 
especially in the heat. It has been suggested that increased PV could improve 
thermoregulation and exercise performance in the heat (Sims et al., 2007b). 
Acute increases in PV induced by pre-exercise ingestion of solutions 
containing CIT and NaCl were associated with improved endurance cycling 
(Sims et al., 2007a) and running (Sims et al., 2007b) capacity in the heat in 
endurance-trained women and men, respectively. However, Vaher et al. (2015) 
reported no impact of acute pre-exercise CIT ingestion that induced water 
retention and significant increase in PV, on 5 km running performance in warm 
environment in non-heat-acclimated endurance-trained males. The number of 
studies conducted in the heat is too small to draw any definite conclusions. 
 
 
2.5. Summary of the review of literature 
Major physiological determinants of endurance ability are VO2max, lactate 
threshold and exercise economy (Joyner and Coyle, 2008; Midgley et al., 2007; 
Pate and Branch, 1992), which can all be significantly improved by systematic 
endurance training. Many nutritional factors like carbohydrates (Jeukendrup et 
al., 2014; Jeukendrup and Jentjens, 2000), water (Holland et al., 2017) and 
several dietary supplements (Burke, 2007; Maughan et al., 2018) may acutely 
influence endurance ability of trained as well as untrained individuals. Besides 
training and nutritional status, environmental factors like temperature and RH 
have impact on endurance ability (Cheuvront et al., 2010; Sawka et al., 2011). 
As far as dietary supplements are concerned, the positive effect of CAF on 
endurance ability is well established (Burke, 2007; Burke et al., 2013; Doherty 
and Smith, 2004; Maughan et al., 2018). This ergogenic effect appears more 
clearly when CAF is administered to well trained persons in capsules containing 
optimal dose (3–6 mg·kg–1) of CAF (Graham, 2001), especially to men, who 
might be more responsive to CAF than women (Adan et al., 2008; Temple et 
al., 2009, 2010). Regarding CIT, there is some evidence suggesting that this 
substance may enhance endurance ability, but the number of relevant studies is 
small, and the findings are not consistent (Burke, 2007; Carr et al., 2011; 
Requena et al., 2005). In studies where performance has been improved, mostly 
500 mg·kg–1 doses of CIT and short-term high-intensity exercise protocols have 
been applied (Carr et al., 2011; Requena et al., 2005). 
In addition, the potential ergogenic properties of both CAF and CIT have 
been mainly evaluated under moderate environmental conditions, with only a 
few studies conducted in warm environments. Although it is widely recognized 
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that CAF improves endurance ability in temperate environmental conditions, its 
efficacy in the heat is not clear. Indeed, the majority of well-controlled studies 
(Cheuvront et al., 2009; Cohen et al., 1996; Roelands et al., 2011) have found 
no benefits of acute CAF ingestion on endurance ability in the heat, with one 
yielding equivocal results (Pitchford et al., 2014) and only one (Ganio et al., 
2011) demonstrating ergogenic effect. Data on the potential impact of CIT on 
endurance ability in the heat are even more scarce. Two studies, where 
participants ingested CIT combined with NaCl, reported increased time to 
exhaustion in trained women in cycling (Sims et al., 2007a) and in trained men 
in running (Sims et al., 2007b), whereas one study did not find any impact, 
positive or negative, of CIT ingestion on 5 km running performance in trained 
men (Vaher et al., 2015). 
The findings of the majority of relevant studies suggest that acute orally 
induced metabolic alkalosis alleviates exercise stress, as reflected in attenuated 
stress hormone responses to exercise (Bouissou et al., 1988; Gordon et al., 
1994; Rojas Vega et al., 2006; Ööpik et al., 2010; Wahl et al., 2010). However, 
all these studies were carried out in temperate environmental conditions and 
investigated relatively short-duration high-intensity exercise bouts. On the other 
hand, prolonged exercise in the heat compared to the same exercise performed 
in a temperate environment induces greater increases in blood prolactin (PRL) 
(Burk et al., 2012; Sparks et al., 2005), growth hormone (GH) (Niess et al., 
2003; Ööpik et al., 2014), cortisol (CORT) (Satarifard et al., 2012; Tamm et al., 
2015) and aldosterone (ALDO) (Akerman et al., 2017) levels, but to the best of 
our knowledge, it is unknown whether CIT (or NaHCO3) ingestion alleviates 
responses of stress hormones to prolonged endurance exercise in warm 
environments. 
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3. RESEARCH AIMS AND HYPOTHESIS 
The main purpose of this study was to determine the effects of caffeine and 
sodium citrate ingestion on endurance ability in recreationally active female and 
male participants performing in the heat. 
 
Specific aims and hypotheses of the study were:  
1. To compare the impact of acute caffeine ingestion on psychological and 
physiological parameters in young female and male participants walking to 
exhaustion in the heat. We hypothesized that the endurance- and mood-
enhancing effect of caffeine would appear in males only or would be greater 
in males than in females. 
2. To assess the impact of sodium citrate ingestion during recovery from 
dehydrating execise on rehydration, plasma volume, ratings of perceived 
exertion and thermoregulation. We hypothesized that sodium citrate, 
stimulating rehydration and inducing expansion of plasma volume slow 
down increases in core body temperature and improve performance in warm 
environment in male non-heat-acclimated endurance athletes. 
3. To test the hypothesis that sodium citrate ingestion during 16-h recovery 
period after dehydrating cycling exercise, in an amount that has been shown 
to induce metabolic alkalosis and expansion of plasma volume, would 
attenuate increases in the blood levels of cortisol, aldosterone, growth 
hormone and prolactin during subsequent 40-km time-trial in the heat.  
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4. METHODS 
4.1. Participants 
A total of forty three healthy, recreationally active male and female athletes 
(Table 1) volunteered to participate in 2 studies, the protocols of which were 
approved by the Research Ethics Committee of the University of Tartu, and 
these conformed to the standards set by the Declaration of Helsinki. Before the 
study, all participants were informed of the nature of the investigation, after 
which they gave written consent. All the volunteers were nonsmokers, they 
were involved in endurance-type recreational activities 3–4 times a week. They 
neither had history of heat illness nor had they travelled to a warm climate at 
least 2 months before the study. All female participants were users of 
contraceptive pills. 
 
Table 1. Participants’ anthropometric parameters 
Study Gender Number 
of 
partici-
pants 
Age 
(years) 
Body 
mass (kg) 
Height (cm) VO2peak 
(ml·min–1·kg–1) 
Caffeine: Male 13 24.9 ± 4.1 78.8 ± 7.9 182.7 ± 5.5 51.7 ± 2.7 
 Female 10 22.5 ± 2.0 61.0 ± 5.4 167.3 ± 5.2 45.6 ± 4.0 
Sodium 
citrate 
Male 20 30.8 ± 5.4 78.2 ± 8.4 182.5 ± 6.9 57.0 ± 5.9 
Data are presented as mean ± SD. 
 
 
4.2. Study designs 
4.2.1. Caffeine study 
The participants visited the laboratory on 4 occasions. During the first visit they 
were familiarized with the study protocol and the equipment to be affixed to 
their bodies. Anthropometric measurements were taken and peak oxygen uptake 
(VO2peak) was determined in a temperate environment (air temperature, 21–
22 °C; relative humidity (RH), 50–51%) using an online breath-by-breath 
metabolic system (MasterScreen CPX; Viasys Healthcare GmbH, Hoechberg, 
Germany) and a motorized treadmill (Viasys/Jaeger LE300 C; Viasys Health-
care GmbH), as described by Burk and colleagues (2012). During the second 
visit the participants completed a 20-min treadmill walk in warm-dry environ-
mental conditions (42 °C; RH 20%) in a climatic chamber (Design Environ-
mental Ltd.; Gwent, South Wales, UK). The purpose of this exercise session 
was to familiarize the participants with the walking exercise and psychological 
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testing procedures and to minimize any anxiety effects during the experimental 
trials. 
 During both the third and fourth visit to the laboratory, the endurance capa-
city of each participant was measured in the same environmental conditions 
(i.e., 42 °C; RH 20%). The participants walked on a treadmill at 60% of their 
thermoneutral VO2peak until volitional exhaustion after CAF and PLC 
administration in a randomly assigned, double-blind, crossover manner, with 1 
week between the 2 experimental trials.  
The participants were instructed to refrain from alcohol, CAF, and strenuous 
exercise for 24 h before each visit to the laboratory. To ensure similar nutri-
tional and hydration status and physical activity level before all the testing 
sessions, the participants were instructed to record their dietary intake and 
physical activity during the day before their first visit to the laboratory and to 
follow the same regimen before the consecutive visits.  
 
 
4.2.2. Experimental trials in caffeine study 
On each trial day (Figure 1), the participants reported to the laboratory 1 h after 
breakfast (i.e., at 8:00 am). They voided and donated a urine sample. Then, in 
the CAF trial, the participants were administered a total of 6 mg·kg–1 of CAF 
(Oriola, Finland) in gelatine capsules in 2 doses: 60 min (4 mg·kg–1) and 
immediately (2 mg·kg–1) before the endurance capacity test. In the PLC trial, 
the participants were administered wheat flour in the same amount and 
according to the same protocol. On both occasions, the participants were 
advised to ingest the capsules with a bolus of water. 
 
Figure 1. Testing day protocol. Arrows indicate time points at which outcome measures 
were collected or supplements administered. 20 min indicates the duration that 
participants spent in a standing position before blood sampling. BM, body mass; 
Tc, core body temperature; Tsk, skin temperature; HR, heart rate; 1st/2nd dose, caffeine or 
placebo administration; RPF, ratings of perceived fatigue; RPE, ratings of perceived 
exertion; TS, thermal sensation; VASA, visual analogue scale for perceived arousal; 
VASM, visual analogue scale for mood; CFF, critical flicker frequency.  
 
 
 
 
 
 
 
 
 
 
 
 
VASA 
VASM 
CFF 
VASA 
VASM 
CFF
BM 
Urine Blood 
1st  
dose 
Blood 
BM
Blood
2nd 
dose 
                          20 min  water ad libitum, HR, Tc, Tsk, RPF, RPE, TS 
Preparatory phase 50 min walk Walk to exhaustion10 min rest
VASA 
VASM
CFF
27 
Fifteen minutes before entering the climatic chamber, the nude BM of the 
participants was measured. Thereafter they positioned rectal temperature probe, 
heart rate (HR) transmitter strap and skin temperature probes were attached to 
their bodies.  
After entering the climatic chamber, the participants stood still on the 
treadmill for 20 min before blood sampling and starting the endurance capacity 
test. During the test, the intensity of the exercise was adjusted individually to 
60% of participant’s personal thermoneutral VO2peak by using a constant speed 
of 6 km·h–1 and regulating the grade of the treadmill. In both the CAF and the 
PLC trials, the endurance capacity test included 2 periods of walking separated 
by 10-min rest interval while participants stood on the treadmill. The first 
walking period lasted for 50 min, and the second until volitional exhaustion. One 
of the research group members was responsible for premature termination of the 
endurance capacity test if one of the following conditions was observed in the 
participant: (i) a rise of Tc to 40 °C for 5 min; (ii) a rise of HR to 95% of age-
predicted maximal HR for 5 min; (iii) the occurrence of symptoms of exertional 
heat illness, such as nausea, dizziness, or headache; or (iv) a participant’s 
request to stop. 
During the endurance capacity test, the participants were allowed to drink 
water ad libitum, and the volume of water consumed was registered. Whole-
body sweat production was calculated on the basis of changes in nude BM 
during exercise, taking into account the volume of water consumed. Capillary 
blood samples were taken from the fingertips of the participants immediately 
before the start of the endurance capacity test (Pre-Ex), immediately after the first  
50-min walking period (Mid-Ex), and at the time of volitional exhaustion  
(Post-Ex).  
Ratings of overall perception of exertion (RPE) and fatigue (RPF) (Borg, 
1998) and thermal sensation (TS) (BSI, 2001) were recorded at 10-min intervals 
throughout each endurance capacity test. A visual analogue scale (VAS) for 
recording perceived arousal (VASA) and mood (VASM) and critical flicker 
frequency (CFF) for assessment of cortical arousal (Simonson and Brozek, 
1952) were used before the start of the endurance capacity test, during the 10-min 
rest interval between the 2 walking periods, and at the cessation of the exercise 
test. Changes in cortical arousal and CNS activity have been registered reliably 
using the CFF threshold, in relation to CAF ingestion (Hindmarch et al. 1998) 
as well as to exercise (Davranche and Pichon 2005). The CFF threshold, 
defined as the frequency at which a flickering light is indistinguishable from a 
steady, nonflickering light, was used for further analysis. 
After the endurance capacity test, the participants were asked to indicate 
whether they believed they had received CAF or PLC and how confident they 
were in the answer provided. These subjective ratings were converted into the 
confidence percentage of receiving caffeine (subjCAF).  
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4.2.3. Sodium citrate study 
The study consisted of the preparatory phase and the main phase. The partici-
pants visited laboratory on 3 occasions in the preparatory phase and 4 times in 
the main phase. During the first visit to the laboratory, anthropometric measure-
ments of the participants were collected, they were familiarized with the equip-
ment to be affixed to their bodies as well as with all the experimental proce-
dures. Their VO2peak was determined in a temperate environment (21–22 °C; 
RH 50–51%) using the same online breath-by-breath metabolic system as in 
CAF study, but using different incremental workload test on a Cyclus 2 ergo-
meter (RBM Elektronik-Automation GmbH, Leipzig, Germany). The protocol 
started with a warm-up period of 2.5 min at a workload of 100 W. Thereafter, 
the workload was increased by 50 W after every 2.5 min until exhaustion. 
On the second and the third visits to the laboratory, the participants comp-
leted the 40-km familiarization cycling TTs in the heat (32 °C; RH 46%) to 
minimize any potential learning and anxiety effects.  
On the first day of the main phase of the study participants exercised on 
cycle ergometer in the heat until they lost approximately 4% of BM. During  
16-h recovery period participants drank bottled water ad libitum, ate prescribed 
diet and ingested gelatine capsules containing either CIT or PLC (sucrose) in 
randomly assigned double-blind crossover manner with 1 week between the 
2 trials. In the morning of the next day, 2 h after having prescribed breakfast, 
participants performed 40-km TT in the heat (32 °C; RH 46%). 
Participants were instructed to record their 24-h dietary intake before starting 
the main phase of the study with the PLC or the CIT trial. Before their second 
trial in the main phase, the records were returned to the participants with 
instructions to follow the same diet for 24 h prior to their visit to the laboratory. 
Participants were also instructed to refrain from exercise for 24 h before trials.  
 
 
4.2.4. Experimental trials in sodium citrate study 
In the afternoon of the first day of the main phase participants performed 
dehydrating cycling exercise (DE) followed by the 40-km TT in the next 
morning (Figure 2). Both trials took place in the climatic chamber where air 
temperature was set to 32 °C and RH to 46%.  
Participants reported to the laboratory at 2:30 pm, voided, donated a urine 
sample, and then their nude BM was measured. Prior to entering climatic 
chamber, the participants positioned rectal temperature probe and they were 
fitted with a HR transmitter strap. After entering the climatic chamber, the 
participants sat on a chair for 20 min prior to blood sampling and start of DE. 
The intensity of work during DE was individually adjusted to 50%‒60% of 
VO2peak. 
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Figure 2. Main phase protocol. Arrows indicate time points at which outcome measures 
were collected, supplements administered, or TT started/finished. 20 min indicate the 
duration that participants spent in a sitting position before blood sampling and 5 min 
indicate the duration of standardized warm-up. BM, body mass; Tc, core body 
temperature; Tsk, skin temperature; HR, heart rate; 1st/2nd/3rd dose, sodium citrate or 
placebo administration; RPF, ratings of perceived fatigue; RPE, ratings of perceived 
exertion. 
 
Initially all participants performed 3 sets of 20-min cycling followed by a  
10-min rest without drinking. During the third 10-min rest, participants towel-
dried themselves and they were weighed wearing only cycling shorts and socks. 
On the basis of individual BM loss it was calculated how many 20-min cycling 
sets each participant had to complete to achieve 4% dehydration level. 
Immediately after DE participants removed all the affixed equipment, towel-
dried themselves, and their nude BM was measured for calculating the actual 
dehydration level achieved. 
During 16-h recovery period participants were allowed to drink bottled water 
ad libitum, and the volume consumed was precisely recorded. After DE, at 
approximately 40 min prior to leaving the laboratory, all participants ate a meal 
that provided 20 kcal·kg‒1 initial BM (69% carbohydrates, 11% proteins, 20% 
fats). Right before this meal, participants were administered the first dose 
(200 mg·kg‒1 initial BM) of CIT or PLC. When leaving the laboratory, each 
participant received a small plastic bag with gelatine capsules containing the 
second 200 mg·kg‒1 dose of CIT or PLC. Participants were instructed to ingest 
this dose of supplement with a bolus of water at approximately 1 h before 
bedtime at home.  
Next morning the participants reported to the laboratory at 8:00 am and ate 
breakfast, which, together with the third 200 mg·kg‒1 dose of CIT or PLC, 
provided 12 kcal·kg‒1 BM (80% carbohydrates, 9% proteins, 11% fats). About 
an hour after the breakfast participants voided and donated a urine sample. 
Their nude BM was measured, they positioned rectal temperature probe and HR 
transmitter strap, and skin temperature probes were attached to their bodies. 
After entering the climatic chamber, participants sat still on a chair for 20 min. 
Then venous and capillary blood samples were collected, RPE and RPF were 
recorded (Borg, 1998).  
 
 
 
 
 
 
 
 
 
 
 
 
BM 
Urine Blood Blood 
BM 
1st dose 
START FINISH 
Blood 
BM 
RPF 
Blood 
BM 
2nd dose 
3rd dose 
 Urine RPF 
 20 Tc; HR; Controlled diet; water  20        5 Tc; Tsk; HR; RPE; water  
Dehydration exercise  16 h recovery period 40-km TT warm-up 
30 
Cycling started at 2 h after breakfast. Initially participants performed a 5-min 
warm-up and after 2-min rest they started a flat 40-km TT, the profile of which 
was created using the Cyclus 2 software (Skorski et al. 2015). Participants were 
instructed to complete the TT as fast as possible and they were given verbal 
encouragement by one of the research group members. The same range of 
electronic gear ratios was used for each trial, and participants started both trials 
with the same gear ratio. RPE was recorded at 5-km intervals throughout TT 
and RPF right before and after the 40-km TT. During TT, the participants were 
allowed to drink water ad libitum. After TT participants were asked to indicate 
whether they believe they had ingested CIT or PLC.  
 
 
4.3. Blood sampling and biochemical analyses 
In both of the studies (CAF and CIT) lactate concentration in the capillary blood 
samples was measured enzymatically (Dr Lange Cuvette Test LKM 140; 
Dr Lange, Berlin, Germany) using the miniphotometer LP 20 Plus (Dr Lange, 
Berlin, Germany). Hemoglobin concentration and hematocrit were measured 
from capillary blood samples in CAF study, and from venous blood samples in 
CIT study, using blood analyzer Celltac α MEK-6108K (Nihon Kohden, Tokyo, 
Japan). The values obtained were used for calculation of relative changes in PV 
(Dill and Costill, 1974). 
In CIT study venous blood samples were collected from antecubital vein 
before and after DE and TT into sterile serum Vacutainer tubes as well as into 
Vacutainer tubes containing EDTA. The collected blood was allowed to clot for 
10 min at room temperature and was then centrifuged (Eppendorf 5804R; 
Eppendoff AG, Hamburg, Germany) for 10 min at 3000 rpm at 4 °C. The 
separated serum was used for assessment of hydration status (for details see 
below). Serum and plasma specimens were maintained at ‒25 °C until assayed 
for hormones and metabolites.  
Glucose concentration in serum was measured using the hexokinase enzymatic 
method on Roche/Hitachi Cobas 6000 c501 analyser (Roche Diagnostics GmbH, 
Mannheim, Germany).  
ALDO and GH concentrations were measured in plasma and serum, 
respectively, with chemiluminescence immunoassay method and using IDS-
iSYS Multi-Discipline Automated Analyser (Immunodiagnostic Systems 
Limited, Boldon Colliery, UK). Concentrations of PRL and CORT were 
measured in serum using electrochemiluminescence immunoassay “ECLIA” on 
Cobas 6000 e601 analyzer (Roche Diagnostics GmbH, Mannheim, Germany).  
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4.4. Thermoregulatory measurements 
Core body temperature (Tc) was measured using a rectal temperature probe 
(REC-UU-VL5-0; Grant Instruments Ltd, Cambridge, UK), which participants 
positioned at 10 cm beyond the anal sphincter. Tc was recorded every 1 min using 
an electronic data logger (SQ2020-1F8; Grant Instruments Ltd, Cambridge, 
UK). 
Skin temperature was registered in 4 sites (arm, chest, thigh, leg) by means 
of 4 miniature temperature probes DS1922L (Maxim Integrated Products Inc., 
San Jose, CA, USA), which were attached on the same side of the body using a 
sticking plaster. Skin temperature was recorded every 1 min and the data were 
transferred to a computer using the appropriate device (DS1401-4+; Maxim 
Integrated Products Inc., San Jose, CA, USA).  
Weighted mean skin temperature (Tsk) was calculated according to Rama-
nathan (1964). Tc and Tsk were used for calculation of temperature gradient (Tgr): 
Tgr = Tc–Tsk in CIT study, and for calculation of mean body temperature (Tb) 
according to Colin et al. (1971): Tb = 0.2 Tsk + 0.8 Tc, in CAF study. 
 
 
4.5. Assessment of hydration status 
Hydration status in CAF study was assessed on the basis of urine specific 
gravity (USG), urine osmolality (UOsm), BM, sweat production, water intake, 
and changes in PV. Hydration status during the main phase of the CIT study 
was assessed on the basis of USG, serum osmolality (SOsm), BM, water 
retention, and changes in PV. USG was measured by means of a digital clinical 
refractometer (PDX-CL; VeeGee Scientific Inc., Kirkland, WA, USA). UOsm 
and SOsm were measured using freezing point depression osmometer Model 
3250 (Advanced Instruments Inc., Norwood, Mass., USA). BM changes were 
calculated on the basis of values measured before and after trial using electronic 
scale (CH3G–150I Combics; Sartorius AG, Goettingen, Germany). Whole-body 
sweat production was calculated on the basis of changes in nude BM, taking 
into account the volume of water consumed during the trial, which was precisely 
registered by one of the research group members. Water retention during the  
16-h recovery period in CIT study was calculated as difference between the 
volumes of water consumed and urine passed.  
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4.6. Heart rate monitoring 
In CAF study the participants were fitted with a HR transmitter strap (Suunto 
Dual Belt; Suunto OY, Vantaa, Finland) and their HR was recorded by means 
of a telemetry system (Suunto PC POD; Suunto OY, Vantaa, Finland). 
In CIT study the participants were also fitted with a HR transmitter strap, but 
HR was recorded continuously with heart rate monitor Polar RS800CX and 
analyzed with Polar Protrainer 5 software (Polar Electro Oy, Kempele, Finland). 
 
 
4.7. Gastrointestinal distress monitoring 
Gastrointestinal symptoms monitoring was done only in CIT study. Gastro-
intestinal symptoms experienced by the participants during the 16-h recovery 
period and TT were recorded as described by Cameron et al. (2010). Question-
naires consisted of eight 100-mm VAS with no symptoms on the left-hand side 
and severe symptoms on the right-hand side. Participants were asked to rate 
their symptoms. If they had no symptoms, they made no mark on the VAS. If 
they were experiencing some symptoms, they indicated their overall rating by 
placing a vertical mark on the appropriate scale. The VAS was used to measure 
symptoms of nausea, flatulence, stomach cramping, stomachache, belching, 
vomiting, bowel urgency, and diarrhea. 
 
 
4.8. Statistical analysis 
In both studies the Statistica software was used for performing statistical 
analysis. Data are presented as mean ± SD. All data were checked for normal 
distribution using Kolmogorov-Smirnov test. In CAF study three-factor mixed-
model analysis of variance (ANOVA) was used to examine the effects of 
gender (between factor) and trial and time (within factors) for Tc, Tsk, Tb, HR, 
BM, blood lactate concentration and perceptual ratings. Two-factor mixed-
model ANOVA was employed for analysis of the effect of gender (between 
factor) and trial (within factor) on USG, UOsm, water intake, sweat production 
and PV data. In CIT study two-factor (trial x time) repeated-measures ANOVA 
was used to evaluate the differences within and between the trials for BM, 
SOsm, PV, Tc, Tsk, Tgr, RPE, RPF, HR, blood biochemical parameters, split 
times and power output. The number of time points assessed varied with 
measurements, depending on the specific outcome measure. In case a signi-
ficant main effect was observed, Tukey’s honestly significant difference post 
hoc analysis was used to locate differences between the means. Differences 
between PLC and CIT trials in variables measured at a single time point (energy 
intake, water intake, sweat loss, urine volume, water retention, USG, TT time 
and work done) were analyzed using paired-samples Studentʼs t-test. The χ2 
analysis was used to compare the prevalence of gastrointestinal distress 
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symptoms in the PLC and CIT trials. Significant deviations from sphericity 
were tested with Mauchly’s sphericity test. When a violation of sphericity was 
observed, the Greenhouse-Geisser correction was employed and corrected p 
values are reported in the CAF study. In both studies relationships between 
variables were determined on the basis of Pearson correlation coefficient (r). 
Significance was set at p < 0.05 level while the p values < 0.1 are reported to 
indicate trends. The hormone and glucose concentrations measured after the  
40-km TT in the CIT study are presented as corrected for the individual changes 
in PV. 
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5. RESULTS 
5.1. Caffeine study 
Endurance capacity 
 
There was no main effect of CAF ingestion (F = 2.22, p = 0.151) or gender 
(F = 0.40, p = 0.534) on endurance capacity: volitional exhaustion occurred 
after 82.1 ± 15.1 min and 75.6 ± 11.2 min of exercise in females and after 
83.1 ± 16.6 min and 81.6 ± 14.4 min in males in the PLC and CAF trials, 
respectively.  
 
 
Blood lactate concentration 
 
Significant main effects of time (F = 40.99, p < 0.001) and trial (F = 43.06, 
p < 0.001), with no between-gender difference (F = 0.045, p = 0.834) were 
observed for blood lactate concentration. Overall, blood lactate concentration 
was higher in the CAF (3.11 ± 1.76 mmol·L–1) than in the PLC (2.12 ± 
0.87 mmol·L–1) trial (p < 0.001). Analyses of the pooled data of males and 
females revealed similar Pre-Ex blood lactate concentrations in the 2 trials, but 
Mid-Ex and Post-Ex blood lactate levels were significantly higher in the CAF 
compared with the PLC trial (Figure 3). 
 
Figure 3. Blood lactate concentration during endurance capacity test. Data are presented 
as mean ± SD. Significantly different (p < 0.05): * from Pre-Ex; # from placebo. 
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Thermoregulatory responses  
 
Significant main effects of gender (F = 5.17, p = 0.034) and time (F = 361.14, 
p < 0.001), with no between-trial difference (F = 0.17, p = 0.688), were evident 
for Tc that increased with the duration of exercise in both females and males. 
Overall, Tc was lower in males (38.2 ± 0.8 °C) compared with females 
(38.4 ± 0.8 °C; p = 0.034), but post hoc analysis revealed no significant difference 
between males and females at any time point (Figure 4A).  
There was a significant main effect of time (F = 108.29, p < 0.001), but not 
of trial (F = 0.35, p = 0.562) or gender (F = 3.09, p = 0.093) on changes in Tsk. 
Tsk increased with the duration of exercise in both trials, with no difference 
between males and females (Figure 4B). 
Significant main effects of gender (F = 5.12, p = 0.034) and time (F = 344.99, 
p < 0.001), with no between-trial difference (F = 0.25, p = 0.623) were evident 
for Tb that increased with the duration of exercise in both females and males. 
Overall, Tb was lower in males (38.0 ± 0.8 °C) than in females (38.2 ± 0.7 °C; 
p = 0.034), but post hoc analysis revealed no significant difference between 
males and females at any time point. 
Figure 4. Core body temperature (A) and mean skin temperature (B) during endurance 
capacity test. Data are presented as mean ± SD. *Significantly different (p < 0.05) from 
time point 0. 
 
 
Body mass and hydration status 
In both females and males USG and UOsm measured in the morning (on arrival 
of the participants in the laboratory) and BM measured before the endurance 
capacity test were similar in the CAF and PLC trials (Table 2). Males were 
significantly heavier compared with females (main effect of gender: F = 38.06, 
p < 0.001), but there was no between-gender difference (F = 0.82, p = 0.376) in 
the magnitude of BM loss during the endurance capacity test (Table 2). There 
were no between-trial differences in total water intake (F = 0.40, p = 0.534) and 
whole-body sweat production (F = 0.002, p = 0.966) or rates of water intake 
(F = 0.11, p = 0.740) and whole-body sweat production (F = 3.00, p = 0.098) 
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during the endurance capacity test. However, all these parameters were 
significantly lower in females compared with males (Table 2). Relative change 
in PV during the endurance capacity test was similar in the 2 trials (F = 1.84, 
p = 0.189), with no difference between males and females (F = 0.00006, 
p = 0.994) (Table 2).  
 
Table 2. Body mass and hydration status 
Parameter 
Female (n = 10) Male (n = 13) 
PLC CAF PLC CAF 
Body mass, kg   
Pre-Ex 60.96±5.55 61.03±5.25 78.61±7.82$ 79.10±7.84$ 
Post-Ex 
Change 
60.31±5.53* 
‒0.65±0.49
60.29±5.18* 
‒0.74±0.60
77.75±7.84*$ 
‒0.85±0.49
78.21±7.70*$ 
‒0.89±0.56 
USG 1.0126±0.0094 1.0138±0.0100 1.0198±0.0088 1.0188±0.0059 
UOsm, 
mOsmol·kg−1
456±303 521±359 791±349$ 774±228 
Water intake: 
mL 
mL·min−1 
 
933±457 
10.2±4.8 
 
829±399 
9.8±4.8
 
1442±690$ 
15.4±6.4$
 
1426±739$ 
15.2±7.2$ 
Sweat 
production  
    
mL 1581±440 1566±459 2294±505$ 2316±515$ 
mL·min−1 16.9±3.1 18.1±4.2 24.6±3.2$ 25.3±3.7$ 
Change in PV 
(%) 
‒5.1±6.1 ‒4.4±5.3 ‒5.3±5.1 ‒4.2±5.0 
Data are presented as mean ± SD. Significantly different (p < 0.05): * from Pre-Ex; $ from female 
participants. Pre-Ex, before test exercise; Post-Ex, after test exercise; USG, urine specific gravity; 
UOsm urine osmolality; PV, plasma volume. 
 
 
Heart rate 
Significant main effects of time (F = 564.22, p < 0.001), trial (F = 7.84, 
p = 0.011), and time by trial interaction (F = 4.00, p = 0.002) were evident for 
HR, with no between-gender difference (F = 4.16, p = 0.054). Overall, HR was 
higher in the CAF (158.0 ± 27.4 beats·min–1) than in the PLC (154.9 ± 26.8 
beats·min–1) trial (p = 0.009). Analysis of the pooled data of females and males 
revealed a significantly lower HR in the PLC compared with the CAF trial after 
40 min of exercise and during the 10-min rest interval between the 2 exercise 
periods (Figure 5). 
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Figure 5. Heart rate during endurance capacity test. Data are presented as mean ± SD.  
Significantly different (p < 0.05): * from time point 0; # from placebo. 
 
 
Ratings of perceived exertion, fatigue and thermal sensation  
There was a significant main effect of time (F = 135.15, p < 0.001), but not of 
trial (F = 2.41, p = 0.136) or gender (F = 0.004, p = 0.951) for the changes in 
RPE. However, significant trial by gender interaction (F = 6.33, p = 0.020) 
revealed an overall between-trial difference in males (13.8 ± 4.3 and 12.7 ± 3.9 
in the PLC and CAF trials, respectively; p = 0.022) but not in females (13.2 ± 
3.3 and 13.4 ± 3.8, respectively; p ˃ 0.05). Post hoc analysis revealed signi-
ficantly lower RPE in the CAF than in the PLC trial in males after 50 min of 
exercise (Figure 6A), but there was no between-trial difference in RPE in 
females at any time point (Figure 6B). 
 
Figure 6. Rating of perceived exertion during endurance capacity test in males (A) and 
females (B). Data are presented as mean ± SD. Significantly different (p < 0.05): *from 
time point 0; # from caffeine. 
 
Significant main effects of time (F = 90.06, p < 0.001) but not of trial (F = 0.25, 
p = 0.624) or gender (F = 0.23, p = 0.635) were observed for the changes in 
RPF. Significant trial by gender interaction (F = 11.03, p = 0.003) revealed an 
overall between-trial difference in males (5.1 ± 3.5 and 4.3 ± 3.1 in the PLC and 
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CAF trials, respectively; p = 0.034) but not in females (4.1 ± 2.2 and 4.7 ± 2.7, 
respectively; p = 0.286). Post hoc analysis revealed significantly lower RPF in 
the CAF than in the PLC trial in males after 40 min of exercise (Figure 7A), but 
there was no between-trial difference in RPF in females at any time point 
(Figure 7B). 
There was a significant main effect of time (F = 10.11, p < 0.001), but not of 
trial (F = 1.00, p = 0.330) or gender (F = 0.005, p = 0.944) for the changes in 
TS. TS increased with the duration of exercise in both trials in both males and 
females. 
 
Figure 7. Rating of perceived fatigue during endurance capacity test in males (A) and 
females (B). Data are presented as mean ± SD. Significantly different (p < 0.05): *from 
time point 0; # from caffeine. 
  
 
Mood and arousal  
Significant main effect of time (F = 13.15, p < 0.001), but not of trial (F = 1.23, 
p = 0.20) or gender (F = 0.15, p = 0.705) was observed for VASM. VASM was 
rated lower during the 10-min rest interval between the 2 walking periods (6.0 ± 
2.2 and 5.5 ± 2.1 in the PLC and CAF trials, respectively) and after cessation of 
the endurance capacity test (6.4 ± 2.1 and 6.5 ± 2.3 in the PLC and CAF trials, 
respectively) compared with the pre-test measure in both trials (8.0 ± 1.2 and 
7.4 ± 1.6 in the PLC and CAF trials, respectively).  
Significant main effect of time (F = 41.41, p < 0.001) also occurred for 
VASA, with lower ratings during the 10-min rest interval between the 2 walking 
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For CFF, the main effect of time was significant (F = 5.40, p < 0.01), 
indicating a higher threshold measure during the 10-min rest interval between 
the 2 walking periods (32.3 ± 4.2 and 32.4 ± 3.9 Hz in the PLC and CAF trials, 
respectively) compared with the pre-test values (31.2 ± 3.5 and 31.2 ± 3.7 Hz in 
the PLC and CAF trials, respectively) and the measures taken after cessation of 
the endurance capacity test (31.1 ± 3.8 and 31.4 ± 3.7 Hz for the PLC and CAF 
trials, respectively). No significant effects of trial (F = 0.95, p = 0.343) or 
gender (F = 1.69, p = 0.210) were observed for CFF. 
  
 
Correlation analysis 
In females, endurance capacity was significantly related to the confidence 
ratings on perception of receiving caffeine (subjCAF; r = –0.71, p < 0.05) in the 
PLC trial, whereas in the CAF trial, endurance capacity was related to RPE 
(r = –0.79, p < 0.05) and RPF (r = –0.70, p < 0.05) recorded at the end of the 
first walking period (at 50 min). In males, endurance capacity was associated 
with RPE and RPF recorded at the end of the first walking period in both the 
PLC trial (RPE, r = –0.78, p < 0.01; RPF, r = –0.87, p < 0.001) and the CAF 
trial (RPE, r = –0.68, p < 0.05; RPF, r = –0.79, p < 0.01). 
 
 
5.2. Sodium citrate study 
Dehydrating exercise 
 
There was main effect of time (F = 193.46, p < 0.001) and significant trial by 
time interaction (F = 63.18, p ˂ 0.001) but no main effect of trial (p > 0.05) for 
BM (Table 3). Likewise, main effect of time (F = 45.80, p < 0.001) and 
significant trial by time interaction (F = 9.11, p ˂ 0.001) but no main effect of 
trial (p > 0.05) were observed for SOsm. Regarding changes in PV, main effects 
of trial (F = 22.51, p < 0.001) and time (F = 131.57, p < 0.001) and significant 
trial by time interaction (F = 27.49, p < 0.001) occurred (Figure 8).  
Prior to DE, BM, SOsm, and USG did not differ in the PLC and CIT trials 
(Table 3). During DE, similar sweat losses and changes in BM, SOsm and PV 
(Figure 8) occurred in the 2 trials. Total time spent in climatic chamber to 
achieve the target dehydration level was 146.8 ± 10.8 min in the PLC and 147.2 
± 11.1 min in the CIT trial (p > 0.05). 
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Table 3. Body mass and hydration status. 
Parameter 
Placebo Citrate
DE 40-km TT DE 40-km TT 
Body mass, kg   
 Pre-Ex 79.83±9.00 79.70±9.03 79.63±8.71 80.29±8.99 #$ 
 Post-Ex 76.90 ± 8.88* 78.35±9.03* 76.71±8.59* 79.11±7.70* 
Body mass change 
 kg 
 % 
 
‒2.93±0.42 
‒3.69±0.56
 
‒1.36±0.60 
‒1.72±0.79
 
‒2.92±0.43 
‒3.69±0.56
 
‒1.18±0.69 $ 
‒1.49±0.89 $ 
Pre-Ex USG 1.0113±0.0086 1.0119±0.0093 1.0119±0.0061 1.0113±0.0074 
SOsm, mOsmol·kg−1   
 Pre-Ex 292.0±3.8 292.2±2.9 290.8±3.8 295.5±3.3 #$ 
 Post-Ex 302.1±5.1* 296.4±6.3* 302.3±3.8* 298.2±6.7* 
Water intake, mL ‒ 1285±420 ‒ 1529±611 $ 
Sweat production    
 mL 2926±416 2642±393 2922±430 2711±381 
 L·h−1 ‒ 2.33±0.35 ‒ 2.39±0.36 
Data are presented as means ± SD, n = 20. Significantly different (p < 0.05): * from Pre-Ex; # 
from DE; $ from placebo trial. DE, dehydrating cycling exercise; Pre-Ex, before test exercise; 
Post-Ex, after test exercise; SOsm, serum osmolality; TT, time-trial; USG, urine specific gravity.  
 
 
Figure 8. Changes in plasma volume during dehydrating cycling exercise (DE), 16-h 
recovery period (RECOVERY), and subsequent 40-km time-trial (TT). Data are 
presented as means ± SD, n = 20. *Significantly different (p < 0.05) from placebo. 
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Recovery after dehydrating exercise 
Actual energy intake within the 16-h recovery period after DE was similar in 
the 2 trials. During evening meal participants consumed 1585 ± 226 kcal 
(20.1 ± 3.3 kcal·kg‒1) in the PLC and 1589 ± 204 kcal (20.1 ± 3.0 kcal·kg‒1) in 
the CIT trial (p > 0.05). During breakfast their energy intake was 851 ± 182 kcal 
(10.8 ± 2.6 kcal·kg‒1) in the PLC and 825 ± 186 kcal (10.4 ± 2.6 kcal·kg‒1) in 
the CIT trial (p > 0.05). 
Water content of the food consumed during recovery period was similar in 
the PLC and CIT trials (2106 ± 310 mL and 2131 ± 300 mL, respectively; 
p > 0.05). However, drinking water consumption (2855 ± 684 mL in PLC and 
3364 ± 612 mL in CIT; p < 0.001) and total water intake (4962 ± 739 mL; 
62.6 ± 10.4 mL·kg‒1 in PLC and 5495 ±721 mL; 69.4 ± 9.7 mL·kg‒1 in CIT; 
p < 0.001) were greater in the CIT trial. The volume of urine passed during 
recovery period did not differ in the 2 trials (1500 ± 653 mL in PLC and 
1369 ± 394 mL in CIT; p > 0.05), but water retention was significantly 
(p < 0.001) higher in the CIT trial (4126 ± 592 mL) than in the PLC 
(3462 ± 486 mL) trial. Greater increase in PV occurred in the CIT trial compared 
with the PLC trial (p < 0.001; Figure 8).  
By the end of recovery period, i.e., immediately prior to 40-km TT, SOsm 
had returned to the level observed prior to DE in the PLC trial, but still 
remained elevated in the CIT trial (Table 3). Moreover, immediately prior to the 
40-km TT, SOsm was higher in the CIT trial compared with the PLC trial. BM 
gain in the CIT trial (4.68% ± 0.71%) significantly (p < 0.001) exceeded that 
observed in the PLC trial (3.67% ± 0.75%). In both the PLC and CIT trials, 
changes in BM strongly correlated with water retention: r = 0.854 and r = 0.932, 
respectively, in both occasions p < 0.001. At the end of the 16-h recovery period, 
i.e., immediately prior to 40-km TT, BM of the participants was greater in the 
CIT than in the PLC trial (Table 3). 
 
 
Time-trial performance  
Cycling 40-km TT time in the PLC and CIT trials (68.1 ± 2.9 min and 
68.1 ± 3.3 min, respectively) did not differ (p > 0.05). There was no main effect 
of trial on split times (Figure 9A) or power output (Figure 9B, p > 0.05 in both 
cases), but significant main effect of time was evident on both split times 
(F = 16.40, p < 0.001) and power output (F = 22.52, p < 0.001). Significant trial 
by time interaction on split times (F = 2.146, p = 0.044) and power (F = 3.599, 
p < 0.01) was observed, but post hoc analysis did not reveal any significant 
between-trial difference in split times or power output during any single 5-km 
segment. Nevertheless, a trend (p = 0.079) towards higher power output 
occurred in the CIT trial (238.0 ± 32.8 W) compared with the PLC trial (226.9 ± 
28.8 W) during the final 5-km segment of the 40-km TT. 
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Figure 9. Average 5-km split times (A) and average power output on 5-km segments 
(B) of the 40-km time-trial. Data are presented as means ± SD, n = 18. *Significantly 
different (p < 0.05) from the first 5-km segment. 
 
 
Blood Biochemical Parameters 
 
Significant main effects of time (F = 96.83, p ˂ 0.001), trial (F = 32.18, p ˂ 
0.001) and trial by time interaction (F = 23.11, p ˂ 0.001) were evident for 
plasma ALDO concentration. ALDO levels were lower in the CIT trial 
compared with the PLC trial before (p ˂ 0.001) and after (p ˂ 0.001) TT (Figure 
10A). During 40-km TT ALDO levels increased in both trials, but the 
magnitude of the increase was smaller in the CIT trial than in the PLC trial 
(p ˂ 0.001). 
Regarding serum CORT levels, time (F = 34.23, p ˂ 0.001) and trial (F = 
21.41, p ˂ 0.001) significant main effects, but no trial by time interaction (F = 
1.36, p = 0.257) were found. CORT levels were lower in the CIT trial compared 
with the PLC trial before (p = 0.039) and after (p = 0.001) 40-km TT (Figure 
10B). However, the magnitude of increases in CORT levels during 40-km TT 
was similar in the 2 trials. 
Serum PRL and GH concentrations showed significant main effects of time 
(F = 84.91, p ˂ 0.001 and F = 99.02, p ˂ 0.001, respectively), but no main 
effects of trial (F = 3.00, p = 0.099 and F = 1.39, p = 0.254, respectively) or time 
by trial interactions (F = 3.87, p = 0.064 and F = 0.57, p = 0.460, respectively). 
Significant increase in concentrations of PRL (p ˂ 0.001) and GH (p ˂ 0.001) 
occurred during 40-km TT, but the magnitude of these increases was similar in 
the 2 trials (Figure 10C and 10D). 
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Figure 10. Plasma aldosterone (A), serum cortisol (B), prolactin (C), and growth 
hormone (D) concentration in placebo (PLC) and sodium citrate (CIT) trials before and 
after 40-km time-trial. “Change” was calculated as hormone concentration “After” 
minus hormone concentration “Before”. Data are presented as means ± SD, n = 20. 
Significantly different (p < 0.05): * from Before; # from PLC. 
 
Significant main effects of trial (F = 23.42, p < 0.001) and time (F = 132.13, p < 
0.001) and trial by time interaction (F = 17.71, p < 0.001) for blood lactate 
concentration were observed. Prior to 40-km TT blood lactate levels were 
similar in the PLC and CIT trials (Figure 11A). However, during 40-km TT, the 
extent of an increase in blood lactate concentration was greater (p < 0.001) in 
the CIT trial than in the PLC trial. Therefore, after finishing the 40-km TT 
higher blood lactate level was observed in the CIT trial compared with the PLC 
trial (p < 0.001). 
Regarding serum glucose concentration, a significant main effect of time 
(F = 5.40, p = 0.031) and time by trial interaction (F = 6.43, p = 0.020), but no 
trial main effect (F = 1.01, p = 0.327) were found. Prior to 40-km TT, serum 
glucose concentration did not differ in the 2 trials (p = 0.844), but after exercise 
glucose level tended to be lower in the CIT trial compared with the PLC trial 
(p = 0.055) (Figure 11B). However, during 40-km TT, the extent of a decrease 
in serum glucose concentration was greater in the CIT trial compared with the 
PLC trial (p = 0.020). Therefore, after finishing the 40-km TT, serum glucose 
concentration had fallen below the before exercise level in the CIT (p ˂ 0.001) 
but not in the PLC trial (p = 0.643). 
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Figure 11. Blood lactate (A) and serum glycose (B) concentration before and after  
40-km TT. “Change” was calculated as lactate/glucose concentration “After” minus 
lactate/glucose concentration “Before”. Data are presented as means ± SD, n = 20. 
Significantly different (p < 0.05): * from before; # from placebo. 
 
 
Thermoregulatory responses during time-trial 
Significant main effect of time (F = 243.53, p < 0.001) and time by trial inter-
action (F = 3.10, p < 0.001) were evident for changes in Tc. Post hoc analysis 
revealed significantly higher Tc (p = 0.033) in the PLC trial (39.65 ± 0.52 °C) 
than in the CIT trial (39.54 ± 0.50 °C) at the finish of the 40-km TT (Figure 
12A).  
There was a significant main effect of time (F = 60.77, p < 0.001) but not of 
trial (p > 0.05) for mean Tsk (Figure 12B). No time by trial interaction effect 
(p > 0.05) was observed for Tsk.  
Significant main effect of time (F = 119.79, p < 0.001) was evident for Tgr; 
however, no main effects of trial or trial by time interaction (p > 0.05 in both 
cases) for Tgr were observed. Tgr increased from 2.40 to 3.34 °C and from 2.39 
to 3.31 °C in the PLC and CIT trials, respectively (in both occasions p < 0.001). 
 
Figure 12. Core body temperature (A) and mean skin temperature (B) during 40-km 
time-trial. Data are presented as means ± SD, n = 20. Significantly different (p < 0.05): 
* from time point 0; # from placebo.  
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Hydration status during time-trial 
During 40-km TT, reduction in BM was greater in the PLC trial compared with 
the CIT trial (Table 3). Water intake in the CIT trial significantly (19%, 
p = 0.002) exceeded that observed in the PLC trial, but sweat losses were 
similar in the 2 trials. Likewise, the extent of an increase in SOsm and that of a 
decrease in PV (Figure 8) did not differ in the 2 trials during 40-km TT. 
However, at the end of the performance test compared with the pre-DE time 
point, PV had decreased to a lower level in the PLC trial than in the CIT trial 
(p < 0.001; Figure 8). 
 
 
Heart rate during time-trial 
A significant main effect of time (F = 297.94, p < 0.001) and trial by time 
interaction (F = 3.70, p < 0.001) were evident for HR, but there was no main 
effect of trial (p > 0.05). HR registered immediately before the start of the  
40-km TT was higher (p < 0.001) in the CIT trial (95.6 ± 12.9 beats·min‒1) 
compared with the PLC trial (89.6 ± 11.5 beats·min‒1) (Figure 13).  
 
 
Figure 13. Heart rate during 40-km time-trial. Data are presented as means ± SD, 
n = 19. Significantly different (p < 0.05): * from time point 0; # from placebo. 
 
 
Ratings of perceived exertion and fatigue during time-trial 
No main effect of trial was observed for RPE or RPF (p > 0.05 in both cases), 
but main effect of time was evident for both RPE (F = 439.83, p < 0.001) and 
RPF (F = 544.42, p < 0.001). Significantly higher (p < 0.05) RPE levels were 
evident already after 5-km of cycling compared to time point 0. There was no 
trial by time interactions for RPE or RPF (p > 0.05 in both cases). At the 
beginning (CIT, 6.1 ± 0.3; PLC, 6.5 ± 1.0; p > 0.05) and end (CIT, 19.3 ± 0.9; 
PLC, 19.5 ± 0.8; p > 0.05) of the 40-km TT similar levels of RPE were recorded 
in the 2 trials. Also similar levels of RPF in both trials were recorded at the 
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beginning (CIT, 1.1 ± 0.9; PLC, 1.2 ± 1.1; p > 0.05) and end (CIT, 9.0 ± 1.6; 
PLC, 9.4 ± 1.2; p > 0.05) of the 40-km TT.  
 
 
Gastrointestinal distress 
Prevalence of GI symptoms was similar in the PLC (6 reports) and CIT 
(10 reports) trials (χ2 = 1.67, p > 0.05). Four participants reported moderate 
flatulence and one felt bowel urgency in the evening preceding the 40-km TT in 
the PLC trial. Two of these four participants mentioned very mild stomach ache 
in the evening preceding the 40-km TT in the CIT trial. Three participants 
reported mild diarrhea before 40-km TT only in the CIT trial. One participant 
vomited during 40-km TT in both trials. At the end of the experimental part of 
the study, exactly half of the participants correctly figured out the substance that 
they had administered in the 2 trials. 
 
 
Correlation analysis 
During TT, the only hormone the increases of which significantly correlated 
with increases in blood lactate concentration was CORT and the relationship 
occurred only in the PLC trial: r = 0.566, p = 0.009. The only hormone the 
increases of which significantly correlated with increases in Tc was PRL: 
r = 0.609 (p = 0.004) in the PLC trial and r = 0.572 (p = 0.008) in the CIT trial. 
Based on pooled data from PLC and CIT trials, plasma ALDO levels before TT 
correlated with changes in PV during time interval between the beginning of 
DE and end of the recovery period (r = ‒0.520, p = 0.001). Moreover, plasma 
ALDO levels after TT correlated with changes in PV during time interval 
between the beginning of DE and end of TT (r = ‒0.338, p = 0.033). Finally, 
based on pooled data from PLC and CIT trials, serum CORT levels before TT 
correlated with serum glucose concentrations after exercise (r = 0.429, p = 0.006). 
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6. DISCUSSION 
6.1. Caffeine study 
This study was unique because its design allowed direct comparison of the 
effects of CAF in female and male participants exercising in the heat. We hypo-
thesized that the endurance-enhancing effect of CAF would appear in males 
only or would be greater in males than in females. The results demonstrate that 
CAF did not reveal any ergogenic effect in female participants, but, contrary to 
our hypothesis, it also had no impact on endurance capacity in males. 
Nevertheless, CAF decreased RPE and RPF in males, but not in females.  
Our participants became hyperthermic (Tc above 38 °C) within the first 20–
30 min of moderate-intensity exercise. Hyperthermia induced central fatigue 
appears to become most relevant during prolonged moderate-intensity exercise, 
whereas reduced oxygen delivery to active muscles may limit performance 
during high intensity exercise only (Nybo, 2008). Martin and Rattey (2007) and 
Russ and Kent-Braun (2003) have shown that central fatigue is a more 
important performance-limiting factor in men than in women. Recently, Adan 
and colleagues (2008) demonstrated greater effects (less somnolence and greater 
activation) of CAF in men than in women, and this observation is in line with that 
of Botella and Parra (2003). On the other hand, there is strong evidence for a 
CNS-mediated endurance-enhancing effect of CAF from animal experiments 
(Davis et al., 2003), and a central mechanism of action of CAF is considered to 
be involved in improving endurance in humans as well (Tarnopolsky, 2008). 
Taken together, these data (Adan et al., 2008; Botella and Parra, 2003; Davis et 
al., 2003; Martin and Rattey, 2007; Russ and Kent-Braun, 2003; Tarnopolsky, 
2008) suggest that, regarding endurance capacity in the heat, females may 
benefit less than do males, or even not at all, from acute pre-exercise CAF 
ingestion. The findings of the current study support this suggestion, because 
CAF had no ergogenic effect at all in our female participants. 
Another unique aspect of this study was the use of a test that consisted of a 
treadmill walk to exhaustion. We used a time to exhaustion treadmill protocol 
with the intention of creating the most favorable conditions for detecting a 
putative endurance-enhancing effect of CAF in a warm environment. Con-
sidering that even the potentially less appropriate cycling TT-s have yielded 
some evidence for the presence of an ergogenic effect of CAF in the heat in 
non-heat-acclimated males (Ganio et al., 2011; Pitchford et al., 2014), we 
expected to corroborate these data. However, contrary to our expectation, but 
similar to the findings of Cheuvront and colleagues (2009) and Roelands and 
colleagues (2011), CAF had no impact on endurance ability in our male 
participants. 
Cheuvront and colleagues (2009) and Roelands and colleagues (2011) 
administered a single 6–9 mg·kg–1 dose of CAF to their participants and 
reported that CAF increased Tc during exercise in the heat. Furthermore, 
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Roelands and colleagues (2011) suggested that such thermogenic effect might 
negate any potential ergogenic benefit of CAF in the heat. Pitchford and 
colleagues (2014), on the basis of their own findings and those of Ganio and 
colleagues (2011), speculated that relatively small doses of CAF, or a 
distribution of bigger doses, may prevent the thermogenic effect of CAF and 
increase the likelihood of an ergogenic effect of this drug in warm conditions. 
Our findings partially support this view, because we administered CAF in 2 
small doses and observed similar Tc, Tsk, and Tb in the CAF and PLC trials. 
However, prevention of CAF’s thermogenic effect did not improve endurance 
capacity in our participants. Consequently, the thermogenic potential of CAF is 
not a satisfactory explanation for the absence of an ergogenic effect of this drug 
in warm environments. 
Our observation of an increased blood lactate response to exercise in the 
CAF compared with the PLC trial is in accordance with the findings of 
Cheuvront and colleagues (2009), but most other relevant studies (Cohen et al., 
1996; Ganio et al., 2011; Roelands et al., 2011) have reported no impact of CAF 
on blood lactate levels during exercise in the heat. Exercise HR in the heat has 
been reported to be not influenced by CAF (Cheuvront et al., 2009; Ganio et al., 
2011; Pitchford et al., 2014; Roelands et al., 2011; Zhang et al., 2014), but our 
participants’ HRs were greater in the CAF than in the PLC trial, although the 
difference was small (approximately 3 beats·min–1). As a novel finding, we 
observed no between-gender differences in the influence of CAF on blood 
lactate levels or HR during exercise in the heat. 
Dehydration, especially in excess of 2% of BM and combined with a high 
Tsk, markedly impairs endurance performance (Sawka et al., 2012). Cohen and 
colleagues (1996) suggested that dehydration in the magnitude of approximately 
4% of BM, with a concomitant > 10% average reduction in PV, abolished any 
possible ergogenic effect of CAF in their runners. Our participants were 
hydrated equally at the beginning of the PLC and CAF trials, as evidenced by 
similar morning USG and UOsm and pre-exercise BM. Approximately 59%–
63% of sweat loss that occurred during exercise was compensated for by simul-
taneous water intake, resulting in merely a 1.1%–1.2% BM loss and a 4.2%–
5.3% reduction in PV, both of which could be considered modest changes. 
Similar BM and PV decreases in the PLC and CAF trials suggest that CAF had 
no impact on hydration status during exercise. Average Tsk, however, reached 
38 °C during exercise. This value is much higher than that (approximately 33 
°C) observed in participants who improved endurance performance in the heat 
with CAF ingestion (Ganio et al., 2011). Hot skin is considered a primary factor 
impairing aerobic exercise performance, independent of hydration status and Tc 
(Sawka et al., 2012). Thus, a high Tsk may be one factor that abolished the 
endurance-enhancing effect of CAF in our participants.  
Meta-analysis revealed that in temperate environmental conditions, CAF, 
compared with PLC, may increase exercise performance by approximately 11% 
and that an average 5.6% reduction in RPE obtained during exercise may 
account for approximately 29% of the ergogenic effect of this drug (Doherty 
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and Smith, 2005). The same meta-analysis concluded that effort sense and 
fatigue experienced at the conclusion of exhausting exercise are essentially the 
same, regardless of treatment. There is a paucity of data concerning the impact 
of CAF on RPE during exercise in the heat. Some authors have reported similar 
RPE values in CAF and PLC trials in males, but the measures were taken in the 
final minute only (Cheuvront et al., 2009) or at the end of the performance test 
(Ganio et al., 2011; Roelands et al., 2011). Pitchford and colleagues (2014) and 
Zhang and colleagues (2014) obtained RPE values from males, and Cohen and 
colleagues (1996) from a mixed group of males and females, at several time 
points during exercise and also found that the average RPE in the CAF-
supplemented trial did not differ from that in the PLC trial. In our male 
participants, the average RPE was significantly (7.5%) lower during exercise in 
the CAF than in the PLC trial, but contrary to the males, there was no impact of 
CAF on RPE in females. Reduction in RPE is considered one of the main CNS 
related actions of CAF leading to improved endurance in temperate 
environments (Doherty and Smith, 2005; Tarnopolsky, 2008). Thus, the data 
regarding our male participants suggest that some factor, possibly a fed state 
and/or a high Tsk, may abolish the beneficial effect of lowered RPE on 
endurance ability in the heat. 
Similar to RPE scores, RPF scores obtained from our male participants 
during exercise were significantly (on an average, 15.5%) lower in the CAF 
compared with the PLC trial, with no between trial difference in females. 
Generally, our RPE and RPF data are in accordance with previous observations 
(Adan et al., 2008; Botella and Parra, 2003; Temple et al., 2009, 2010) about a 
greater sensitivity of men than women to acute CAF ingestion. In line with the 
reports of others (Cheuvront et al., 2009; Roelands et al., 2011), our study 
showed that CAF ingestion did not change TS in our participants.  
Similar to Zhang and colleagues (2014), we observed deterioration in mood 
and perceived arousal during exercise in the heat, but no effect of CAF on these 
estimates. At the same time, the CFF threshold indicated an increase in cortical 
arousal. Considering that CAF’s stimulating impact on mood is well 
documented in temperate environmental conditions (Lorist and Tops, 2003; 
Smith et al., 1999), our data and that of Zhang and colleagues (2014) suggest 
that exposure to combined exercise and heat stress may mask the effects of CAF 
on the psychological state. 
The PLC effect, defined as a change attributable only to an individual’s 
belief in the efficacy of treatment, has been demonstrated to improve physical 
performance in well-trained male cyclists (Beedie et al., 2006) and in untrained 
healthy males (Pollo et al., 2008) who believed they had ingested CAF but were 
actually administered PLC. Surprisingly, in our female participants, but not in 
our male participants, a stronger belief that they had been administered CAF 
was associated with a lower endurance capacity. To the best of our knowledge, 
only Adan and colleagues (2008) have previously reported gender differences in 
the occurrence of a PLC effect: they found that decaffeinated coffee produced a 
greater decrease in somnolence and a more pronounced increase in activation in 
50 
women than in men. In addition, anxiety sensitivity has been found to moderate 
a negative psychological response to CAF (Keogh and Chaloner, 2002), 
especially in women (Keogh and Birkby, 1999). The underlying mechanism of 
these effects is presumed to be the negative interpretive bias: individuals high in 
anxiety sensitivity might misinterpret bodily sensations associated with CAF 
ingestion and respond in a more negative manner (Telch et al., 1996). These 
moderating effects of anxiety sensitivity might explain the observed negative 
association between the belief of ingesting CAF and endurance capacity in the 
heat in females. However, because we did not measure anxiety sensitivity in our 
participants, further studies are needed to explore in more detail the occurrence 
of gender differences in psychological response to endurance exercise in the 
heat after CAF ingestion. 
Our CAF study has limitations. First, the type of oral contraceptives used by 
the female participants and the participants’ stage in their contraceptive cycle 
was not controlled. Oral contraceptives prolong the elimination half-life of CAF 
(Patwardhan et al., 1980) and may have led to different CAF levels between the 
sexes, even though the women and men ingested the same relative dose. Oral 
contraceptives may also influence HR and Tc responses during exercise in the 
heat (Martin and Buono, 1997). Considering that our female participants used 
contraceptives in both trials, the specific impact of contraceptives on HR and Tc 
could be expected to be more or less equal under the CAF and PLC treatments. 
Second, the nutrient content of the breakfast on the trial days was not analyzed 
quantitatively. However, the dietary intake of the participants was well controlled 
qualitatively to ensure similar nutritional and hydration status before all the 
testing sessions. Nevertheless, the findings of Desbrow and colleagues (2009) 
and Acker-Hewitt and colleagues (2012) suggest that a fed state may eliminate 
the ergogenic effect of CAF on endurance performance that has often been 
observed in fasted participants. Because our participants were tested 2 h after 
breakfast, their fed state may be one factor that hindered the occurrence of the 
endurance-enhancing properties of CAF. 
 
 
6.2. Sodium citrate study 
Our study is the first to investigate whether CIT ingestion during recovery from 
DE improves cycling performance during subsequent 40-km TT in a warm 
environment. Also this study investigates whether CIT ingestion in the amount 
that has been shown to induce metabolic alkalosis and an acute increase in PV 
(Timpmann et al., 2012) influences the responses of blood stress hormones to 
prolonged self-paced cycling exercise in a warm environment. The main 
findings of the study are that CIT compared with PLC enhanced rehydration 
and increased PV, but had minor impact on thermoregulation and did not 
influence cycling performance in the heat in recreationally active male non-
heat-acclimated endurance athletes. The novel aspect demonstrates the capacity 
of CIT to reduce blood ALDO levels during exercise-heat stress that is strong 
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stimulus for ALDO secretion (Akerman et al., 2017). Similarly to ALDO, after 
CIT ingestion, significantly lower blood CORT levels occurred prior to and 
immediately after completing the TT. However, there was no between-trial 
difference in the magnitude of the increases in CORT levels that occurred during 
exercise. CIT ingestion did not influence GH and PRL levels in our participants. 
Assuming that our participants were in a euvolemic status before DE, prior 
to 40-km TT their PV had expanded by 7.8% in the CIT trial compared with 
0.9% shrinkage observed in the PLC trial. Acute PV expansion in the range of 
7%–8% may improve endurance ability by 20%–25% (Mora-Rodriguez and 
Hamouti, 2013), but our participants’ TT time was similar after CIT and PLC 
ingestion. We are aware of 4 published studies addressing the potential impact 
of acute PV expansion or pre-exercise hyperhydration on endurance cycling 
ability in a warm environment. Improved TT performance (Hamouti et al., 
2014) and prolonged time to exhaustion (Sims et al., 2007a) were observed in 
association with 4%–5% increases in PV, and improved TT performance was 
also reported owing to increased pre-exercise water retention in the range of 
577–673 mL (Morris et al., 2015). In contrast to these results, Watt et al. (2000) 
found no influence of 13.1% acute PV expansion on TT performance. 
Several factors may explain discrepancy in the results of different studies 
regarding the impact of acute pre-exercise PV expansion or hyperhydration on 
endurance cycling performance in the heat. First, TT performance may be 
influenced by the ability to maintain increased PV throughout exercise bout. 
Indeed, participants studied by Hamouti et al. (2014) maintained hypervolemic 
state throughout TT and achieved higher mean power output compared with 
euvolemic condition, whereas participants in the study conducted by Watt et al. 
(2000) experienced rapid loss of PV expansion at an early stage of exercise and 
did not improve performance. Nevertheless, in our participants persistent hyper-
volemic and hyperhydrated state in the CIT trial compared with the PLC trial 
did not result in improved performance. 
Second, endurance cycling ability after acute pre-exercise PV expansion or 
hyperhydration may depend on the availability of drinking water during exercise 
in the heat. Notably, in all previous studies that reported improved TT perfor-
mance (Hamouti et al., 2014; Morris et al., 2015) or prolonged time to exhaus-
tion (Sims et al., 2007a), no fluids were consumed during exercise, whereas our 
participants drank water ad libitum. Arnaoutis et al. (2012) demonstrated that, 
possibly through activation of pharyngeal receptors, even a small volume of 
water ingested during endurance exercise increased time to exhaustion in the 
heat in dehydrated trained cyclists. Thus, it seems possible that freely available 
drinking water during TT masked the potential ergogenic effect of acute pre-
exercise PV expansion in our participants.  
Third, the impact of acute pre-exercise PV expansion or hyperhydration on 
cycling performance may be influenced by the duration of TT in the heat. In 
previous studies (Hamouti et al., 2014; Morris et al., 2015) performance tests 
began with 120 and 60 min of cycling at constant work rate, but the TT segment 
of the tests lasted merely 10.0–10.4 min and 12.2–14.4 min, respectively. As we 
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intended to mimic a cycling competition, our participants completed a 40-km 
TT, the duration of which was much longer (~68 min). Hamouti et al. (2014) 
and Morris et al. (2015) reported 7.4% higher mean power output and 9.2%–
11.4% shorter TT completion time after inducing pre-exercise hypervolemia or 
hyperhydration, respectively. We only observed a tendency towards greater 
power output during the final 5-km segment of the 40-km TT in the CIT trial 
compared with the PLC trial. Thus, it appears that a chance for improving 
performance owing to acute pre-exercise hypervolemia or hyperhydration may 
be greater during relatively short (up to approximately 15 min) than in longer 
(over 1 h) cycling TTs in the heat. 
Sims et al. (2007a, 2007b) suggested that increased PV provides more fluid 
for redistribution, a benefit of which is slower rise in Tc that may contribute to 
increased time to exhaustion during constant-pace cycling or running in the 
heat. This suggestion is supported by observation of enhanced sweating 
responsiveness during exercise in the heat in hypervolemic state (Fortney et al., 
1981). However, in our participants during the CIT trial, persistent hyper-
volemia was observed, but the time course of rise in Tc and sweat rate were 
similar after CIT and PLC supplementation. Marginally (by 0.1 °C) lower Tc in 
the CIT trial compared with the PLC trial only occurred at the end of 40-km TT. 
Similarly, Hamouti et al. (2014) and Morris et al. (2015) observed minor impact 
of acute PV expansion or hyperhydration on Tc and sweat rate during sub-
sequent cycling TT in the heat. Nevertheless, contrary to us, both groups 
(Morris et al., 2015; Hamouti et al., 2014) reported improved TT performance 
in conditions of hypervolemia or hyperhydration. Altogether the literature and 
the data of the current study suggest that better control of Tc achieved through 
acute PV expansion may partially explain improved endurance capacity in the 
heat, but the influence of hypervolemia on cycling TT performance appears to 
depend on other mechanisms. 
Hamouti et al. (2014) concluded that pre-exercise PV expansion improves 
cycling TT performance in the heat through better maintenance of stroke 
volume and cardiac output during exercise. However, actually they measured 
these parameters during cycling at constant work rate, but not during subsequent 
TT. We only recorded HR that was not influenced by PV expansion during 40-
km TT. This finding is consistent with the observations of others (Hamouti et 
al., 2014; Morris et al., 2015; Watt et al., 2000). 
There is evidence that hot skin (defined as Tsk > 35 °C), not high Tc, may be 
the primary factor limiting aerobic exercise performance in the heat (Cheuvront 
et al., 2010; Sawka et al., 2012). Hot skin narrows the Tgr, which increases skin 
blood flow and may limit muscle as well as cerebral blood flow (Sawka et al., 
2012). In our participants in both the PLC and CIT trials, narrow Tgr of 2.4–
3.4 °C was observed and Tsk exceeded the level of 35 °C already 5 min after the 
start of 40-km TT and remained persistently above 36 °C since the fifteenth 
minute of exercise. Hamouti et al. (2014) did not report Tsk during TT, but 
during preceding cycling at constant work rate it remained below 35 °C 
independently of PV status. Thus, higher Tsk during TT in our participants 
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compared with the subjects studied by Hamouti et al. (2014) may be one of the 
factors that explain the absence of ergogenic effect of acute hypervolemia in our 
participants.  
Serum hyperosmolality inhibits thermoregulatory responses to heat stress 
(Sawka et al., 2000; Takamata et al., 2001) and acute ingestion of CIT is known 
to result in elevated blood Na+ concentration (Ööpik et al., 2010; Vaher et al., 
2015) that may increase SOsm. In our participants, higher SOsm occurred in the 
CIT trial compared with the PLC trial immediately prior to 40-km TT. 
However, in absolute terms the between-trial difference was small and in either 
trial SOsm did not reach the levels that have been shown to inhibit thermo-
regulatory responses (Takamata et al., 2001). Furthermore, there was no 
between-trial difference in SOsm at the end of 40-km TT. Therefore, we 
consider unlikely that the absence of meaningful thermoregulatory effects was 
caused by increased SOsm in the CIT trial. 
Heat stress increases RPE while anything that alters RPE may affect moti-
vation-driven motor-neural firing and influence physical work ability (Cheuv-
ront et al., 2010). Pre-exercise acute hypervolemia was associated with 
decreased RPE and increased time to exhaustion during constant-load exercise 
in the heat (Sims et al., 2007a, 2007b). Hamouti et al. (2014) and Coles and 
Luetkemeier (2005) reported that in acute hypervolemic state RPE tended to be 
lower at the end of constant-load cycling exercise in the heat and temperate 
environment, respectively, but they did not register RPE during TT that 
followed. Our results suggest that in the presence of hot skin, approximately 8% 
expansion of PV has no impact on RPE or 40-km cycling performance in the 
heat. 
CIT ingestion may improve physical performance in high-intensity exercise 
through inducing metabolic alkalosis and increasing blood buffering capacity 
(Burke et al., 2006; Carr et al., 2011; Requena et al., 2005). In the current study 
we did not measure blood pH, HCO3− concentration, or base excess. However, 
Timpmann et al. (2012), using the same CIT dose and administration protocol, 
observed significant increases in all these 3 parameters. Therefore, we assume 
that CIT provoked metabolic alkalosis in our participants. Considering that 
elevated post-exercise blood lactate level in alkalotic state is a typical finding in 
previous studies (Requena et al., 2005), higher blood lactate concentration in 
the CIT trial than in the PLC trial observed after the 40-km TT could be inter-
preted as indirect evidence of increased blood-buffering capacity. Nevertheless, 
some well-controlled studies have revealed no impact of alkalosis induced by 
CIT (Schabort et al., 2000) or NaHCO3 (Northgraves et al., 2014; Peart et al., 
2013; Price et al., 2003; Raymer et al., 2004) ingestion on blood lactate 
response to exercise. Therefore, lack of definite data characterizing blood-buf-
fering capacity in our participants should be considered one of the limitations of 
our study. 
Potteiger et al. (1996) and Schabort et al. (2000) assessed the potential 
impact of CIT on cycling performance in temperate environment. Potteiger et 
al. (1996) concluded that alkalosis induced by 500 mg·kg−1 of CIT ingestion 
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improved 30-km TT time, whereas Schabort et al. (2000) reported dose-
dependent increases in blood buffering capacity without any change in 40-km 
TT time after administering 200–600 mg·kg−1 of CIT. Our findings add to these 
data, showing that ingestion of 600 mg·kg−1 of CIT during recovery after DE 
has no impact on subsequent 40-km cycling performance in the heat. 
In goats, metabolic alkalosis suppressed blood ALDO concentration in the 
absence of detectable changes in plasma K+ concentration or renin activity 
(Augustinsson et al., 1989), which are considered primary regulators of ALDO 
secretion (Bollag, 2014; El Ghorayeb et al., 2016). However, in sedentary rats, 
alkalosis did not decrease, but rather increased plasma ALDO concentration 
(Lieu et al., 2013). In young men, ingestion of either NaHCO3 or KHCO3 
induced metabolic alkalosis, but neither of these substances suppressed plasma 
ALDO levels (Lindinger et al., 2000). Considering these data, it seems unlikely 
that reduced ALDO levels were induced by metabolic alkalosis in our partici-
pants in CIT trial.  
In temperate environmental conditions, CIT compared to PLC ingestion 
induced higher serum Na+ and lower K+ concentrations (Ööpik et al., 2010) and 
exactly the same pattern of changes in blood ALDO levels as observed in the 
current study. Therefore, it is plausible that a similar impact of CIT on blood 
electrolyte levels occurred in our participants. Increase in K+ is considered a 
strong, and decrease in Na+ a relatively weak, stimulus for ALDO secretion 
(Bollag, 2014; El Ghorayeb et al., 2016). In light of these data, it is likely that 
CIT-induced changes in blood K+ and Na+ concentrations were among the 
factors that reduced ALDO levels in our participants in resting state and during 
exercise in the heat. Unfortunately, the lack of definite data regarding the 
electrolyte levels may be considered as a limitation of this study. 
In temperate environmental conditions, expanded PV and decreased blood 
ALDO levels after CIT ingestion were observed (Ööpik et al., 2010). Others 
(Grant et al., 1996; Roy et al., 2001) induced an acute pre-exercise PV 
expansion by infusion of dextran solution and reported blunted blood ALDO 
responses to prolonged constant-load cycling exercise. As with Grant et al. 
(1996), we observed an inverse relationship between the PV changes and blood 
ALDO levels. Nevertheless, in the study by Grant et al. (1996) the effect of PV 
expansion was manifested only during exercise, whereas in our participants 
decreased blood ALDO level occurred already at resting state prior to the TT. 
This discrepancy could be explained by the specifics of the methods used for 
inducing PV expansion (dextran infusion vs CIT ingestion) and/or by different 
time interval during which pre-exercise PV expansion was achieved (2 h vs 
16 h). Thus, in light of previous data (Grant et al., 1996; Roy et al., 2001; Ööpik 
et al., 2010) our findings suggest that expansion of PV was one of the factors 
that decreased blood ALDO levels at resting state and during exercise in the 
heat.  
Cortisol is among the most widely studied markers of stress (Hackney, 2006; 
Staufenbiel et al., 2013). In a temperate environment, NaHCO3 compared to 
PLC ingestion attenuated serum CORT responses to four consecutive 30 s bouts 
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of maximal cycling exercise (Wahl et al., 2010). These authors concluded that 
exercise-induced acidosis stimulated CORT secretion and that NaHCO3 induced 
metabolic alkalosis was partly responsible for blunted CORT response. Without 
ingestion of alkalizing substances, parallel increases in blood lactate level and 
acidity occur during exercise (Robergs et al., 2004). Therefore, observation that 
during TT in PLC trial increases in serum CORT levels correlated positively 
with changes in lactate concentrations suggests that exercise-induced acidosis 
influenced CORT secretion in our participants. The absence of such correlation 
in CIT trial may be explained by the fact that induced metabolic alkalosis 
facilitates efflux of both lactate and H+ from contracting muscle cells and at the 
same time more efficiently buffers H+, leading to greater elevations in blood 
lactate levels, but attenuating increases in blood acidity (Bishop et al., 2004; 
McNaughton et al., 1999; Potteiger et al., 1996) and CORT levels. 
Cooper et al. (2010) and Rhind et al. (2004) reported a significant relation-
ship between exercise-induced increases in Tc and plasma CORT levels. In our 
participants, CIT ingestion induced acute PV expansion that may slow down 
increases in Tc during exercise (Mora-Rodriguez and Hamouti, 2013). However, 
lower serum CORT level in CIT trial occurred already before the start of the TT 
when Tc did not differ. Immediately after exercise, Tc was 0.1 °C lower in CIT 
trial, but the between-trial difference in serum CORT level was similar to that 
observed prior to exercise. Furthermore, increases in Tc did not correlate with 
increases in serum CORT levels during exercise in either trial. Thus, it is 
unlikely that Tc induced between-trial differences in serum CORT level in our 
participants.  
Nutritional status, nutrient timing, intensity and duration of exercise and total 
amount of work completed are important factors influencing endocrine responses 
to exercise (Hackney and Smith-Ryan, 2013; McMurray and Hackney, 2000). 
Our participants’ energy and nutrient intake and timing was carefully controlled 
and kept identical during the 16-h recovery period. Time-trial time and total 
amount of work completed during exercise did not differ in the two trials. Thus, 
these factors could not induce the between-trial differences observed in ALDO 
and CORT levels. Similarly, these factors do not explain greater decrease in 
serum glucose concentration in CIT compared to PLC trial during exercise. On 
the other hand, CORT possesses a crucial role in maintaining blood glucose 
level (McMurray and Hackney, 2000), and it has been shown that during pro-
longed exercise, lower CORT levels are associated with greater decreases in 
plasma glucose concentrations (Scheen et al., 1998). Considering positive 
correlation observed between pre-exercise CORT and post-exercise glucose 
concentrations in our participants, it is plausible that during TT in CIT trial, the 
greater decrease in serum glucose concentration was at least partly due to lower 
CORT level. 
Several-fold increases in serum PRL concentrations occurred during TT, but 
the magnitude of this response was similar in the two trials. Exercise stimulates 
PRL secretion (Rojas Vega et al., 2012), whereas the magnitude of rise in blood 
PRL level in response to similar exercise demands is markedly greater in the 
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heat compared to temperate (Burk et al., 2012; Mündel et al., 2010) or cold 
(Brisson et al., 1986; Pitsiladis et al., 2002) environments. De Meirleir et al. 
(1985) suggested that the trigger mechanism of PRL release is exercise-induced 
metabolic acidosis, and Rojas Vega et al. (2006) found that metabolic alkalosis 
reduced PRL response to short-duration exhausting exercise in a temperate 
environment. Considering the proven alkalotic effect of the dose used and 
protocol of administration of CIT (Timpmann et al., 2012), our findings suggest 
that orally induced metabolic alkalosis did not affect serum PRL response to TT 
in the heat. 
A significant relationship occurs between Tc and PRL response to exercise 
(Bridge et al., 2003; Brisson et al., 1991; Burk et al., 2012; Strachan et al., 2004). 
Our data are consistent with this observation as exercise-induced increases in 
serum PRL concentrations correlated with increases in Tc. Taken together, our 
data suggest that increases in Tc stimulate PRL secretion during prolonged 
cycling exercise in the heat and that CIT ingestion does not modulate serum 
PRL response in this situation.  
Secretory stimuli are similar for PRL and GH (Rojas Vega et al., 2006). 
Similar general patterns of GH and PRL serum levels in our participants, 
including the absence of any effect of CIT ingestion, are in accordance with this 
notion. However, Gordon et al. (1994) and Wahl et al. (2010) reported that 
metabolic alkalosis attenuated blood GH response to short-term high-intensity 
exercise in temperate environmental conditions. Assuming that our participants 
were in an alkalotic state in CIT trial, our data suggest that alkalosis did not 
modulate serum GH responses to prolonged exercise in the heat. 
Literature shows, with a few exceptions (Bridge et al., 2003; Laing et al., 
2008), that GH secretion is sensitive to increases in Tc (Christensen et al., 1984; 
Niess et al., 2003; Pitsiladis et al., 2002), and that positive relationships occur 
between Tc and GH levels during prolonged exercise in the cold (Wheldon et 
al., 2006) and in the heat (Ftaiti et al., 2008; Rhind et al., 2004; Ööpik et al., 
2014). However, all previous studies which revealed direct relationship between 
exercise-induced changes in Tc and blood GH levels employed constant-load 
exercise of fixed duration (Ftaiti et al., 2008; Rhind et al., 2004; Wheldon et al., 
2006) or to volitional exhaustion (Ööpik et al., 2014), whereas in the current 
study, the participants performed self-paced TT. Thus, the mode of self-pacing 
protocol might be a factor confounding the relationship between changes in Tc 
and serum GH in our participants. Nevertheless, our data reveal that in the heat, 
prolonged self-paced cycling exercise induces immense increases in serum GH 
levels, and that CIT ingestion does not modulate GH response in these 
conditions.  
Gastrointestinal distress concomitant with ingestion of alkalizing substances 
is considered an important factor reducing potential performance-enhancing 
effect and limiting the use of these substances in sports (Burke and Pyne, 2007). 
Schabort et al. (2000) considered it possible that failure of CIT to produce 
improvements in cycling performance could have been due to gastrointestinal 
distress experienced by their participants. In the current study, 7 participants 
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reported mild gastrointestinal symptoms, but the prevalence and severity of 
these symptoms did not differ in the 2 experimental trials. Thus, gastrointestinal 
distress was apparently not the reason for absence of ergogenic effect of CIT in 
our participants. 
To summarize, the main likely reasons why CIT supplementation, despite 
exerting positive impact on rehydration and PV, did not influence endurance 
cycling performance were availability of drinking water and occurrence of high 
Tsk during TT. Our findings of reduced ALDO and CORT levels before and 
after TT and blunted acute response of ALDO to TT suggest that CIT ingestion 
after DE alleviates stress during subsequent heavy endurance cycling bout in a 
warm environment. As suggested by Peart et al. (2013), reduced stress during 
exercise may lead to improved recovery. This possibility deserves further 
research, because in multi-stage road cycling races, improved recovery between 
stages may strongly influence the final rankings of the competitors. Therefore, 
investigating only one exercise-recovery-exercise cycle may be considered an 
important limitation of this study.  
58 
7. CONCLUSIONS 
1. Caffeine induced greater increases in heart rate and blood lactate con-
centrations during exercise in the heat in both non-heat-acclimated males 
and females, but had no impact on changes in body temperature, cortical 
arousal, perceived arousal, or mood in participants of either gender. Caffeine 
decreased ratings of perceived exertion and ratings of perceived fatigue in 
males, but not in females. Nevertheless, caffeine did not influence endurance 
capacity in the heat in participants of either gender. 
 
2. Sodium citrate ingestion during the 16-h recovery period after exercise-
induced dehydration promotes water retention, enhances rehydration, in-
creases plasma volume, and facilitates body mass regain, but has no impact 
on thermoregulation, ratings of perceived exertion, or 40-km cycling time-
trial time in warm environment in male non-heat-acclimated endurance 
athletes. 
 
3. Sodium citrate compared to placebo ingestion during 16-h recovery period 
after dehydrating cycling exercise results in decreased blood aldosterone and 
cortisol levels prior to and after cycling time-trial in warm environment in 
male non-heat-acclimated endurance athletes. Sodium citrate ingestion also 
reduces the magnitude of acute increases in blood aldosterone, but not 
cortisol level, during time-trial. Sodium citrate ingestion has no influence on 
blood levels of prolactin or growth hormone in these experimental conditions. 
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SUMMARY IN ESTONIAN 
Toidulisandite mõju hindamine vastupidavuslikule töövõimele  
kõrge temperatuuriga keskkonnas 
 
Sissejuhatus 
Vastupidavuslikul töövõimel on spordis ja militaarses kontekstis sageli selgesti 
erinev rakenduslik tähtsus. Spordivõistlustel on praktiliselt alati esmatähtis võime 
läbida kindel vahemaa võimalikult lühikese ajaga. Sõjalistel operatsioonidel on 
seevastu sageli märksa olulisem võime taluda suurt kehalist koormust võima-
likult pika aja vältel. Need vastupidavusliku võimekuse aspektid on erinevate 
toidulisanditega mõjutatavad erineval määral ja eeldatava mõju ulatuse tuvasta-
miseks tuleb kasutada ka vastavaid testimismeetodeid. Näiteks kofeiini ergo-
geenne efekt tuleb kõige paremini esile vastupidavusaladel, mis nõuavad pikka 
või lausa suutlikkuseni pingutust. Seevastu naatriumtsitraati kasutavad sport-
lased valdavalt eesmärgiga suurendada keha puhversüsteemide mahutavust, mis 
parandab sooritusvõimet pigem lühiajalisel (kestusega 1‒7 minutit) kõrge inten-
siivsusega tööl. 
Kuigi kofeiini mõju kehalisele töövõimele ja kognitiivsetele funktsioonidele 
on teaduslikku tähelepanu ja praktilist huvi pälvinud juba pikka aega, on endi-
selt vähe andmeid kofeiini toimest kehalisele töövõimele kõrge temperatuuriga 
keskkonnas ning olemasolevad andmed on vastuolulised. Ka naatriumtsitraadi 
manustamise mõju jalgratturite vastupidavuslikule töövõimele on seni uuritud 
vaid normaalsetes keskkonnatingimustes ja nende uuringute tulemused on samuti 
vastuolulised. Samas kõrge temperatuuriga keskkonnas inimese kehaline töö-
võime langeb ning nii mõnegi toidulisandi mõju võib osutuda erinevaks võrreldes 
normaalse keskkonnaga.  
Seega, käesoleva uurimistöö tulemused lisavad olulist teavet kahe toidulisandi 
(kofeiin ja naatriumtsitraat) manustamise mõjust vastupidavuslikule töövõimele 
kõrge temperatuuriga keskkonnas. Sellekohastel teadmistel on suur praktiline 
väärtus, kuna nii rahvusvahelised spordivõistlused kui ka sõjalised operatsioonid 
toimuvad sageli piirkondades, kus kõrge temperatuur on üheks oluliseks 
töövõimet mõjutavaks faktoriks.  
 
 
Uurimistöö eesmärk 
Uurimistöö peamiseks eesmärgiks oli välja selgitada kahe toidulisandi, kofeiini 
ja naatriumtsitraadi, manustamise mõju aklimatiseerumata treenitud vaatlusaluste 
vastupidavuslikule töövõimele kõrge temperatuuriga keskkonnas. Lisaks oli töö 
eesmärk võrrelda meeste ja naiste vahelisi erinevusi kofeiini akuutse manustamise 
mõjust kognitiivsele töövõimele ning füsioloogilistele funktsioonidele. Naatrium-
tsitraadi uurimise eesmärgiks oli lisaks veel hinnata toimeaine mõju vee-
staatusele, termoregulatsioonile ja stressihormoonide tasemele. 
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Uuritavad ja metoodika 
Uuringus osales vabatahtlikkuse alusel nelikümmend kolm tervet, kehaliselt 
aktiivset mees- ja naissportlast. Uuritavate keskmine (±SD) vanus ja maksimaalne 
hapnikutarbimise võime (VO2max) olid vastavalt: kofeiini uuringus meestel 
24,9 ± 4,1 a ja 51,7 ± 2,7 ml·min–1·kg–1; naistel 22,5 ± 2,0 a ja 45,6 ± 
4,0 ml·min–1·kg–1; ning naatriumtsitraadi uuringus meestel 30,8 ± 5,4 a ja 57,0 ± 
5,9 ml·min–1·kg–1.  
Kofeiini uuringu põhiosa koosnes kahest vastupidavusliku töövõime testist, 
mis seisnesid kõndimises liikuval jooksurajal intensiivsusega 60% VO2max kuni 
kurnatuseni kõrge temperatuuriga kuivas keskkonnas (42 °C; RH 20%). Seevastu 
naatriumtsitraadi uuringu põhifaasis väntasid uuritavad veloergomeetril esmalt 
kõrge temperatuuriga keskkonnas (32 °C; RH 46%) eesmärgiga tekitada ca  
4%-lise ulatusega dehüdratsioon. Seejärel pärast 16-h taastumisaega sooritasid 
uuritavad samades keskkonnatingimustes vastupidavusliku töövõime testi, mis 
seisnes 40 km läbimises võimalikult lühikese ajaga. Mõlema toimeaine uurin-
gud teostati topeltpimeda, randomiseeritud, ristuva uuringukavandi järgi.  
Kofeiini uuringus manustati uuritavatele 60 minutit enne töövõime testi 
algust 4 mg·kg‒1 kofeiini või platseebot ning vahetult enne pingutuse algust veel 
2 mg·kg‒1 kofeiini või platseebot. 
Naatriumtsitraadi uuringu 2 põhifaasi erinevus seisnes taastumisperioodil 
manustatud toidulisandis (naatriumtsitraat või platseebo). Naatriumtsitraati 
manustati kokku 600 mg·kg‒1, mis jaotati 3 võrdseks osaks: esimene kogus 
kapsleid manustati laboris koos õhtusöögiga pärast dehüdratsioonikoormust, 
teine kogus võeti kodus 1 h enne magamaheitmist ning kolmas laboris koos 
hommikusöögiga (2 h enne töövõimetesti). 
 
 
Tulemused 
Tööeelne kofeiini manustamine võrreldes platseeboga vastupidavuslikku töö-
võimet ei mõjutanud (p ˃ 0.05). Mehed suutsid platseebo- ja kofeiiniuuringus 
kõndida vastavalt 83,1 ± 16,6 min ja 81,6 ± 14,4 min ning naised vastavalt 
82,1 ± 15,1 min ja 75,6 ± 11,2 min. Kofeiin võrreldes platseeboga kutsus esile 
ulatuslikuma (p < 0,05) südame löögisageduse ja vere laktaaditaseme tõusu nii 
meestel kui ka naistel. Samas naha- ja süvatemperatuuris erinevusi ei ilmnenud. 
Kofeiin langetas pingutuse subjektiivselt tajutavat raskusastet meestel 
(p = 0,022), aga mitte naistel (p > 0,05). Mehed tajusid väsimust kofeiini manus-
tamise foonil oluliselt väiksemana kui platseebo manustamisel (p = 0,034), naistel 
toimeainevahelist erinevust väsimuse tajumises ei ilmnenud (p = 0,286). 
Naatriumtsitraadi manustamine 16-h taastumisperioodil põhjustas suurema 
veetarbimise, mistõttu ilmnes ka ulatuslikum kehamassi ja plasma mahu taastu-
mine võrreldes platseeboga (p < 0,001). Taastumisperioodile järgneval 40-km 
ajasõidul tarbisid vaatlusalused naatriumtsitraadi uuringus samuti rohkem vett 
ja kehamassi tööaegne langus jäi väiksemaks kui platseebo uuringus (p < 0,05). 
Samas higistamises, plasma mahu muutuses, pingutuse subjektiivselt tajutavas 
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raskusastmes ega ka 40 km läbimise ajas (CIT 68,1 ± 3,3 min, PLC 68,1 ± 
2,9 min) erinevusi ei täheldatud (p > 0,05). Organismi süvatemperatuur oli  
40-km ajasõidu lõpus naatriumtsitraadi uuringus kõigest 0,1 °C madalam kui 
platseebo uuringus. 
Naatriumtsitraadi uuringus ilmnes 72% madalam aldosterooni tase veres 
enne 40-km ajasõitu ja 39% madalam tase pärast sõitu võrreldes platseeboga 
(p ˂ 0,001). Lisaks oli aldosterooni taseme tööaegne tõus veres oluliselt väiksem 
kui platseeboga (p ˂ 0,001). Kortisooli tase veres oli sarnaselt aldosterooniga 
madalam enne (13%, p = 0,039) ja pärast (14%, p = 0,001) töövõime testi, aga 
tööaegses muutuses erinevusi naatriumtsitraadi ja platseebo vahel ei olnud 
(p > 0,05). Prolaktiini ja kasvuhormooni taset naatriumtsitraadi manustamine ei 
mõjutanud (p > 0,05). 
 
 
Järeldused 
1. Kofeiin võrreldes platseeboga tõstab südame löögisagedust ning kutsub esile 
ulatuslikuma tööpuhuse laktaadi kontsentratsiooni tõusu veres, aga ei mõjuta 
naha- ega süvatemperatuuri. Kofeiin vähendab pingutuse subjektiivselt taju-
tavat raskusastet ja väsimuse taju meestel, aga mitte naistel. Kofeiini töö-
eelne manustamine ei paranda noorte aklimatiseerumata meeste ega naiste 
vastupidavuslikku töövõimet kõrge temperatuuriga kuivas keskkonnas. 
2. Naatriumtsitraadi manustamine taastumisperioodil pärast dehüdratsiooni 
soodustab veepeetust, stimuleerib organismi veestaatuse normaliseerumist, 
suurendab plasma mahtu ja hõlbustab kehamassi taastumist, kuid ei mõjuta 
termoregulatsiooni, pingutuse subjektiivselt tajutavat raskusastet ega 40-km 
läbimise aega kõrge temperatuuriga keskkonnas aklimatiseerumata jalg-
ratturitel. 
3. Naatriumtsitraadi manustamine taastumisperioodil pärast ca 4% dehüdrat-
siooni põhjustab madalamat aldosterooni ja kortisooli taset veres võrreldes 
platseeboga vahetult enne ja pärast 40-km ajasõitu kõrge temperatuuriga 
keskkonnas. Naatriumtsitraadi manustamine võrreldes platseeboga aeglustab 
aldosterooni, aga mitte kortisooli taseme tööaegset tõusu. Prolaktiini ja 
kasvuhormooni taset naatriumtsitraadi manustamine võrreldes platseeboga ei 
mõjuta.  
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